Extracapsular Lymph Node Involvement is Associated With Colorectal Liver Metastases and Impact Outcome After Hepatectomy for Colorectal Metastases, Suzuki, Hideki; Fujii, Takaaki; Asao, Takayuki; Tsutsumi, Soichi; Wada, Satoshi; Araki, Kenichiro; Kubo, Norio; Watanabe, Akira; Tsukagoshi, Mariko; Kuwano, Hiroyuki, 2014, WORLD JOURNAL OF SURGERY
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma, Watanabe, Akira; Suzuki, Hideki; Yokobori, Takehiko; Tsukagoshi, Mariko; Altan, Bolag; Kubo, Norio; Suzuki, Shigemasa; Araki, Kenichiro; Wada, Satoshi; Kashiwabara, Kenji; Hosouchi, Yasuo; Kuwano, Hiroyuki, 2014, CANCER SCIENCE
A Resected Case of Mucinous Adenocarcinoma of the Duodenum, Mimicking Intraductal Papillary Neoplasm of the Bile Duct, Kubo, Norio; Suzuki, Hideki; Ishii, Norihiro; Tsukagoshi, Mariko; Watanabe, Akira; Araki, Kenichiro; Wada, Satoshi; Wada, Wataru; Mochida, Yasushi; Saito, Fumiyoshi; Kuwano, Hiroyuki, Nov. 2015, INTERNATIONAL SURGERY
Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer, Suzuki, Hideki; Wada, Satoshi; Araki, Kenichiro; Kubo, Norio; Watanabe, Akira; Tsukagoshi, Mariko; Kuwano, Hiroyuki, 2015, WORLD JOURNAL OF GASTROENTEROLOGY
Aggressive Surgical Resection Combined With Imatinib Therapy for Liver Metastases From a Gastrointestinal Stromal Tumor, Tsukagoshi, Mariko; Suzuki, Hideki; Araki, Kenichiro; Ishii, Norihiro; Watanabe, Akira; Kubo, Norio; Wada, Satoshi; Saito, Fumiyoshi; Kuwano, Hiroyuki, 2015, INTERNATIONAL SURGERY
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma, Suzuki, Hideki; Komuta, Mina; Bolog, Altan; Yokobori, Takehiko; Wada, Satoshi; Araki, Kenichiro; Kubo, Norio; Watanabe, Akira; Tsukagoshi, Mariko; Kuwano, Hiroyuki, 2015, DIGESTIVE AND LIVER DISEASE
Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case, Ishii, Norihiro; Suzuki, Hideki; Tsukagoshi, Mariko; Watanabe, Akira; Kubo, Norio; Araki, Kenichiro; Wada, Satoshi; Kuwano, Hiroyuki, 2015, INTERNATIONAL SURGERY
A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma, Watanabe, Akira; Araki, Kenichiro; Hirai, Keitarou; Kubo, Norio; Igarashi, Takamichi; Tsukagoshi, Mariko; Ishii, Norihiro; Hoshino, Kouki; Kuwano, Hiroyuki; Shirabe, Ken, Dec. 2016, ANNALS OF SURGICAL ONCOLOGY
High expression of karyopherin-2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction, Saito, Fumiyoshi; Araki, Kenichiro; Yokobori, Takehiko; Ishii, Norihiro; Tsukagoshi, Mariko; Watanabe, Akira; Kubo, Norio; Altan, Bolag; Shirabe, Ken; Kuwano, Hiroyuki, 2016, JOURNAL OF SURGICAL ONCOLOGY
Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma, Tsukagoshi, Mariko; Wada, Satoshi; Yokobori, Takehiko; Altan, Bolag; Ishii, Norihiro; Watanabe, Akira; Kubo, Norio; Saito, Fumiyoshi; Araki, Kenichiro; Suzuki, Hideki; Hosouchi, Yasuo; Kuwano, Hiroyuki, 2016, CANCER SCIENCE
Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy, Ishii, Norihiro; Araki, Kenichiro; Yokobori, Takehiko; Watanabe, Akira; Tsukagoshi, Mariko; Kubo, Norio; Suzuki, Hideki; Saito, Fumiyoshi; Altan, Bolag; Hosouchi, Yasuo; Shirabe, Ken; Kuwano, Hiroyuki, 2017, ONCOLOGY LETTERS
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1, Ishii, Norihiro; Araki, Kenichiro; Yokobori, Takehiko; Gantumur, Dorgormaa; Yamanaka, Takahiro; Altan, Bolag; Tsukagoshi, Mariko; Igarashi, Takamichi; Watanabe, Akira; Kubo, Norio; Hosouchi, Yasuo; Kuwano, Hiroyuki; Shirabe, Ken, Dec. 2017, ONCOTARGET
Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review, Kubo, Norio; Araki, Kenichiro; Yamanaka, Takahiro; Hoshino, Kouki; Ishii, Norihiro; Tsukagoshi, Mariko; Igarashi, Takamichi; Watanabe, Akira; Hirai, Keitaro; Saitoh, Fumiyoshi; Kuwano, Hiroyuki; Shirabe, Ken, Oct. 2017, SURGERY TODAY
Enhanced karyopherin-alpha 2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms, Kubo, Norio; Araki, Kenichiro; Altan, Bolag; Hoshino, Kouki; Ishii, Norihiro; Tsukagoshi, Mariko; Igarashi, Takamichi; Watanabe, Akira; Kato, Toshihide; Hirai, Keitaro; Yokobori, Takehiko; Saito, Fumiyoshi; Suzuki, Hideki; Kuwano, Hiroyuki; Shirabe, Ken, 2017, PANCREATOLOGY
Overexpression of karyopherin-alpha 2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins, Tsukagoshi, Mariko; Araki, Kenichiro; Yokobori, Takehiko; Altan, Bolag; Suzuki, Hideki; Kubo, Norio; Watanabe, Akira; Ishii, Norihiro; Hosouchi, Yasuo; Nishiyama, Masahiko; Shirabe, Ken; Kuwano, Hiroyuki, 2017, ONCOTARGET
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression, Igarashi, Takamichi; Araki, Kenichiro; Yokobori, Takehiko; Altan, Bolag; Yamanaka, Takahiro; Ishii, Norihiro; Tsukagoshi, Mariko; Watanabe, Akira; Kubo, Norio; Handa, Tadashi; Hosouchi, Yasuo; Nishiyama, Masahiko; Oyama, Tetsunari; Shirabe, Ken; Kuwano, Hiroyuki, 2017, ONCOTARGET
Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms, Watanabe, Akira; Araki, Kenichiro; Yokobori, Takehiko; Altan, Bolag; Ishii, Norihiro; Tsukagoshi, Mariko; Kubo, Norio; Saito, Fumiyoshi; Suzuki, Hideki; Kuwano, Hiroyuki, 2017, ONCOLOGY LETTERS
Left Lobe Mobilization Strategy of Right-Sided Major Hepatectomy for Treatment of a Tumor Causing Severe Inferior Vena Cava Compression: A Novel Strategy Using the Modified Liver-Hanging Maneuver, Araki, Kenichiro; Kubo, Norio; Ishii, Norihiro; Tsukagoshi, Mariko; Igarashi, Takamichi; Watanabe, Akira; Kuwano, Hiroyuki; Shirabe, Ken, 2018, ANNALS OF SURGICAL ONCOLOGY
Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms, Tsukagoshi, Mariko; Araki, Kenichiro; Saito, Fumiyoshi; Kubo, Norio; Watanabe, Akira; Igarashi, Takamichi; Ishii, Norihiro; Yamanaka, Takahiro; Shirabe, Ken; Kuwano, Hiroyuki, 2018, DIGESTIVE DISEASES AND SCIENCES
Aggressive Surgical Resection Combined With Imatinib Therapy for Liver Metastases From a Gastrointestinal Stromal Tumor, Tsukagoshi, Mariko;Suzuki, Hideki;Araki, Kenichiro;Ishii, Norihiro;Watanabe, Akira;Kubo, Norio;Wada, Satoshi;Saito, Fumiyoshi;Kuwano, Hiroyuki, 2015, INTERNATIONAL SURGERY, 100, 9-10, 1295, 1300
A Resected Case of Mucinous Adenocarcinoma of the Duodenum, Mimicking Intraductal Papillary Neoplasm of the Bile Duct, Kubo, Norio;Suzuki, Hideki;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Araki, Kenichiro;Wada, Satoshi;Wada, Wataru;Mochida, Yasushi;Saito, Fumiyoshi;Kuwano, Hiroyuki, 2015, INTERNATIONAL SURGERY, 100, 11-12, 1443, 1448
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma, Watanabe, Akira;Suzuki, Hideki;Yokobori, Takehiko;Tsukagoshi, Mariko;Altan, Bolag;Kubo, Norio;Suzuki, Shigemasa;Araki, Kenichiro;Wada, Satoshi;Kashiwabara, Kenji;Hosouchi, Yasuo;Kuwano, Hiroyuki, 2014, CANCER SCIENCE, 105, 6, 690, 696
Extracapsular Lymph Node Involvement is Associated With Colorectal Liver Metastases and Impact Outcome After Hepatectomy for Colorectal Metastases, Suzuki, Hideki;Fujii, Takaaki;Asao, Takayuki;Tsutsumi, Soichi;Wada, Satoshi;Araki, Kenichiro;Kubo, Norio;Watanabe, Akira;Tsukagoshi, Mariko;Kuwano, Hiroyuki, 2014, WORLD JOURNAL OF SURGERY, 38, 8, 2079, 2088
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma, Suzuki, Hideki;Komuta, Mina;Bolog, Altan;Yokobori, Takehiko;Wada, Satoshi;Araki, Kenichiro;Kubo, Norio;Watanabe, Akira;Tsukagoshi, Mariko;Kuwano, Hiroyuki, 2015, DIGESTIVE AND LIVER DISEASE, 47, 7, 590, 596
Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer, Suzuki, Hideki;Wada, Satoshi;Araki, Kenichiro;Kubo, Norio;Watanabe, Akira;Tsukagoshi, Mariko;Kuwano, Hiroyuki, 2015, WORLD JOURNAL OF GASTROENTEROLOGY, 21, 35, 10166, 10173
Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case, Ishii, Norihiro;Suzuki, Hideki;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Wada, Satoshi;Kuwano, Hiroyuki, 2015, INTERNATIONAL SURGERY, 100, 6, 1111, 1116
Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma, Tsukagoshi, Mariko;Wada, Satoshi;Yokobori, Takehiko;Altan, Bolag;Ishii, Norihiro;Watanabe, Akira;Kubo, Norio;Saito, Fumiyoshi;Araki, Kenichiro;Suzuki, Hideki;Hosouchi, Yasuo;Kuwano, Hiroyuki, 2016, CANCER SCIENCE, 107, 2, 116, 122
Analysis of the immune suppression mechanism in extra-hepatic cholangiocarcinoma, Wada, Satoshi;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Suzuki, Hideki;Kuwano, Hiroyuki, 2015, CANCER RESEARCH, 75
High expression of karyopherin-2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction, Saito, Fumiyoshi;Araki, Kenichiro;Yokobori, Takehiko;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Altan, Bolag;Shirabe, Ken;Kuwano, Hiroyuki, 2016, JOURNAL OF SURGICAL ONCOLOGY, 114, 4, 462, 468
A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma, Watanabe, Akira;Araki, Kenichiro;Hirai, Keitarou;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Hoshino, Kouki;Kuwano, Hiroyuki;Shirabe, Ken, 2016, ANNALS OF SURGICAL ONCOLOGY, 23, S886, S891
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression, Igarashi, Takamichi;Araki, Kenichiro;Yokobori, Takehiko;Altan, Bolag;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Handa, Tadashi;Hosouchi, Yasuo;Nishiyama, Masahiko;Oyama, Tetsunari;Shirabe, Ken;Kuwano, Hiroyuki, 2017, ONCOTARGET, 8, 7, 12290, 12300
Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms, Watanabe, Akira;Araki, Kenichiro;Yokobori, Takehiko;Altan, Bolag;Ishii, Norihiro;Tsukagoshi, Mariko;Kubo, Norio;Saito, Fumiyoshi;Suzuki, Hideki;Kuwano, Hiroyuki, 2017, ONCOLOGY LETTERS, 13, 3, 1783, 1788
Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy, Ishii, Norihiro;Araki, Kenichiro;Yokobori, Takehiko;Watanabe, Akira;Tsukagoshi, Mariko;Kubo, Norio;Suzuki, Hideki;Saito, Fumiyoshi;Altan, Bolag;Hosouchi, Yasuo;Shirabe, Ken;Kuwano, Hiroyuki, 2017, ONCOLOGY LETTERS, 13, 5, 3653, 3661
Overexpression of karyopherin-alpha 2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins, Tsukagoshi, Mariko;Araki, Kenichiro;Yokobori, Takehiko;Altan, Bolag;Suzuki, Hideki;Kubo, Norio;Watanabe, Akira;Ishii, Norihiro;Hosouchi, Yasuo;Nishiyama, Masahiko;Shirabe, Ken;Kuwano, Hiroyuki, 2017, ONCOTARGET, 8, 26, 42159, 42172
Enhanced karyopherin-alpha 2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms, Kubo, Norio;Araki, Kenichiro;Altan, Bolag;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kato, Toshihide;Hirai, Keitaro;Yokobori, Takehiko;Saito, Fumiyoshi;Suzuki, Hideki;Kuwano, Hiroyuki;Shirabe, Ken, 2017, PANCREATOLOGY, 17, 4, 611, 616
Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review, Kubo, Norio;Araki, Kenichiro;Yamanaka, Takahiro;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Hirai, Keitaro;Saitoh, Fumiyoshi;Kuwano, Hiroyuki;Shirabe, Ken, 2017, SURGERY TODAY, 47, 10, 1173, 1179
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1, Ishii, Norihiro;Araki, Kenichiro;Yokobori, Takehiko;Gantumur, Dorgormaa;Yamanaka, Takahiro;Altan, Bolag;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Hosouchi, Yasuo;Kuwano, Hiroyuki;Shirabe, Ken, 2017, ONCOTARGET, 8, 68, 112636, 112646
High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer, Suzuki, Kazunobu;Watanabe, Akira;Araki, Kenichiro;Yokobori, Takehiko;Harimoto, Norihumi;Gantumur, Dorgormaa;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Kubo, Norio;Gombodorj, Navchaa;Nishiyama, Masahiko;Hosouchi, Yasuo;Kuwano, Hiroyuki;Shirabe, Ken, 2018, ANTICANCER RESEARCH, 38, 2, 939, 944
Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms, Tsukagoshi, Mariko;Araki, Kenichiro;Saito, Fumiyoshi;Kubo, Norio;Watanabe, Akira;Igarashi, Takamichi;Ishii, Norihiro;Yamanaka, Takahiro;Shirabe, Ken;Kuwano, Hiroyuki, 2018, DIGESTIVE DISEASES AND SCIENCES, 63, 4, 860, 867
Left Lobe Mobilization Strategy of Right-Sided Major Hepatectomy for Treatment of a Tumor Causing Severe Inferior Vena Cava Compression: A Novel Strategy Using the Modified Liver-Hanging Maneuver, Araki, Kenichiro;Kubo, Norio;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kuwano, Hiroyuki;Shirabe, Ken, 2018, ANNALS OF SURGICAL ONCOLOGY, 25, 5, 1150, 1151
High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma, Shimoda, Yuki;Ubukata, Yasunari;Handa, Tadashi;Yokobori, Takehiko;Watanabe, Takayoshi;Gantumur, Dolgormaa;Hagiwara, Kei;Yamanaka, Takahiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Harimoto, Norifumi;Katayama, Ayaka;Hikino, Toshiaki;Sano, Takaaki;Ogata, Kyoichi;Kuwano, Hiroyuki;Shirabe, Ken;Oyama, Tetsunari, 2018, BMC CANCER, 18
Skeletal Muscle Volume and Intramuscular Adipose Tissue Are Prognostic Predictors of Postoperative Complications After Hepatic Resection, Harimoto, Norifumi;Hoshino, Hiroki;Muranushi, Ryo;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichirou;Shirabe, Ken, 2018, ANTICANCER RESEARCH, 38, 8, 4933, 4939
Functional analysis of WFA+ Mac-2 Binding Protein (M2BPGi) in hepatocellular carcinoma in vitro, Gantumur, Dolgormaa;Araki, Kenichiro;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Harimoto, Norifumi;Shirabe, Ken, 2018, CANCER SCIENCE, 109, 376, 376
New therapy for hepatocellular carcinoma with liver cirrhosis, targeted to hepatic stellate cells, Yamanaka, Takahiro;Araki, Kenichiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Harimoto, Norifumi;Umezawa, Kazuo;Shirabe, Ken, 2018, CANCER SCIENCE, 109, 941, 941
Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts, Ishii, Norihiro;Araki, Kenichiro;Yokobori, Takehiko;Hagiwara, Kei;Gantumur, Dorgormaa;Yamanaka, Takahiro;Handa, Tadashi;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Harimoto, Norifumi;Masamune, Atsushi;Umezawa, Kazuo;Kuwano, Hiroyuki;Shirabe, Ken, 2019, CANCER SCIENCE, 110, 1, 334, 344
Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma, Watanabe, Akira;Harimoto, Norihumi;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Yamanaka, Takahiro;Yoshizumi, Tomoharu;Shirabe, Ken, 2019, ANTICANCER RESEARCH, 39, 2, 941, 947
Impact of Metabolic Parameters of F-18-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma, Harimoto, Norifumi;Hoshino, Kouki;Muranushi, Ryo;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Araki, Kenichirou;Tomonaga, Hiroyasu;Higuchi, Tetsuya;Tsushima, Yoshito;Shirabe, Ken, 2019, ANTICANCER RESEARCH, 39, 2, 971, 977
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma, Iijima, Misaki;Yokobori, Takehiko;Mogi, Akira;Shimizu, Kimihiro;Yajima, Toshiki;Kosaka, Takayuki;Ohtaki, Yoichi;Obayashi, Kai;Nakazawa, Seshiru;Gombodorj, Navchaa;Tsukagoshi, Mariko;Shirabe, Ken;Kuwano, Hiroyuki, 2019, ANNALS OF SURGICAL ONCOLOGY, 26, 6, 1744, 1750
Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor, Harimoto, Norifumi;Hoshino, Kouki;Muranushi, Ryo;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Araki, Kenichirou;Hosouchi, Yasuo;Suzuki, Hideki;Arakawa, Kazuhisa;Hirai, Keitarou;Fukazawa, Takaharu;Ikota, Hayato;Shirabe, Ken, 2019, PANCREAS, 48, 7, 943, 947
Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm, Igarashi, Takamichi;Harimoto, Norifumi;Nobusawa, Sumihito;Yoshida, Yuka;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Yokobori, Takehiko;Yokoo, Hideaki;Shirabe, Ken, 2019, PANCREAS, 48, 5, E34, E35
Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages, Harimoto, Norifumi;Hoshino, Kouki;Muranushi, Ryo;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Araki, Kenichirou;Hosouchi, Yasuo;Suzuki, Hideki;Arakawa, Kazuhisa;Hirai, Keitarou;Fukazaw, Takaharu;Ikota, Hayato;Shirabe, Ken, 2019, PANCREATOLOGY, 19, 6, 897, 902
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors, Nakazawa, Nobuhiro;Yokobori, Takehiko;Kaira, Kyoichi;Turtoi, Andrei;Baatar, Seded;Gombodorj, Navchaa;Handa, Tadashi;Tsukagoshi, Mariko;Ubukata, Yasunari;Kimura, Akiharu;Kogure, Norimichi;Ogata, Kyoichi;Maeno, Toshitaka;Sohda, Makoto;Yajima, Toshiki;Shimizu, Kimihiro;Mogi, Akira;Kuwano, Hiroyuki;Saeki, Hiroshi;Shirabe, Ken, 2020, ANNALS OF SURGICAL ONCOLOGY, 27, 3, 933, 942
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis, Watanabe, Akira;Harimoto, Norifumi;Yokobori, Takehiko;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Yamanaka, Takahiro;Handa, Tadashi;Oyama, Tetsunari;Higuchi, Tetsuya;Shirabe, Ken, 2020, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25, 2, 322, 329
Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma, Ishii, Norihiro;Harimoto, Norifumi;Araki, Kenichiro;Muranushi, Ryo;Hoshino, Kouki;Hagiwara, Kei;Gantumur, Dolgormaa;Yamanaka, Takahiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Shirabe, Ken, 2019, HEPATOLOGY RESEARCH, 49, 12, 1398, 1405
Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts, Yamanaka, Takahiro;Harimoto, Norifumi;Yokobori, Takehiko;Muranushi, Ryo;Hoshino, Kouki;Hagiwara, Kei;Gantumur, Dolgormaa;Handa, Tadashi;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Shirabe, Ken, 2020, BRITISH JOURNAL OF CANCER, 122, 7, 986, 994
High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer, Hagiwara, Kei;Harimoto, Norifumi;Yokobori, Takehiko;Muranushi, Ryo;Hoshino, Kouki;Gantumur, Dorgormaa;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Tanaka, Hiroshi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Hosouchi, Yasuo;Shirabe, Ken, 2020, ANNALS OF SURGICAL ONCOLOGY, 27, 3, 924, 930
Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment, Araki, Kenichiro;Harimoto, Norifumi;Kubo, Norio;Watanabe, Akira;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Tsushima, Yoshito;Shirabe, Ken, 2020, HPB, 22, 2, 318, 327
Diagnostic value of F-18-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma, Togo, Maria;Yokobori, Takehiko;Shimizu, Kimihiro;Handa, Tadashi;Kaira, Kyoichi;Sano, Takaaki;Tsukagoshi, Mariko;Higuchi, Tetsuya;Yokoo, Satoshi;Shirabe, Ken;Oyama, Tetsunari, 2020, BRITISH JOURNAL OF CANCER, 122, 11, 1686, 1694
Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer, Tsukagoshi, Mariko;Yokobori, Takehiko;Yajima, Toshiki;Maeno, Toshitaka;Shimizu, Kimihiro;Mogi, Akira;Araki, Kenichiro;Harimoto, Norifumi;Shirabe, Ken;Kaira, Kyoichi, 2020, MEDICINE, 99, 7
D-Dimer Could Be a Surrogate Postoperative Prognostic Marker of Resectable Pancreatic Cancer, Watanabe, Akira;Harimoto, Norifumi;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Muranushi, Ryou;Shirabe, Ken, 2020, PANCREAS, 49, 4, E36, E38
Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus, Araki, Kenichiro;Harimoto, Norifumi;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Tsushima, Yoshito;Shirabe, Ken, 2020, SURGERY TODAY
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling, Dolgormaa, Gantumur;Harimoto, Norifumi;Ishii, Norihiro;Yamanaka, Takahiro;Hagiwara, Kei;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Handa, Tadashi;Yokobori, Takehiko;Oyama, Tetsunari;Kuwano, Hiroyuki;Shirabe, Ken, 2020, BRITISH JOURNAL OF CANCER
Albumin-Indocyanine Green Evaluation (ALICE) grade predicts bile leakage after hepatic resection, Harimoto, Norifumi;Muranushi, Ryo;Hoshino, Kouki;Yamanaka, Takahiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Shirabe, Ken, 2020, SURGERY TODAY, 50, 8, 849, 854
Hepatic resection for the right hepatic vein drainage area with indocyanine green fluorescent imaging navigation, Kubo, Norio;Araki, Kenichiro;Harimoto, Norifumi;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Shirabe, Ken, 2020, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 27, 7, 371, 379
Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma, Harimoto, Norifumi;Araki, Kenichiro;Ishii, Norihiro;Muranushi, Ryo;Hoshino, Kouki;Hagiwara, Kei;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Shirabe, Ken, 2020, ANTICANCER RESEARCH, 40, 8, 4343, 4349
Association between intraoperative and postoperative epidural or intravenous patient-controlled analgesia and pancreatic fistula after distal pancreatectomy, Igarashi, Takamichi;Harimoto, Norifumi;Matsui, Yusuke;Muranushi, Ryo;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Saito, Shigeru;Shirabe, Ken, 2020, SURGERY TODAY
Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors, Harimoto, Norifumi;Araki, Kenichiro;Hoshino, Kouki;Muranushi, Ryo;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Tomonaga, Hiroyasu;Higuchi, Tetsuya;Tsushima, Yoshito;Ikota, Hayato;Shirabe, Ken, 2020, WORLD JOURNAL OF SURGERY
VF-012-5 安全で低侵襲なミニループレトラクターを用いた単孔式腹腔鏡下胆嚢摘出術(VF-012 ビデオフォーラム(12)肝臓:腹腔鏡,第111回日本外科学会定期学術集会), 細内 康男;西田 保二;持田 泰;藍原 龍介;神山 陽一;緒方 杏一;小澤 大吾;塚越 真梨子;桑野 博行;浅尾 高行, May 2011, Journal of Japan Surgical Society, 112, 1
YIA-1-4 Stathmin1 (STMN1)は胆管癌において浸潤能・運動能に関与し,術後生存において独立予後因子となる(YIA-1 若手優秀演題賞(1)「肝胆膵」,第114回日本外科学会定期学術集会), 渡辺 亮;鈴木 秀樹;横堀 武彦;塚越 真梨子;久保 憲生;鈴木 茂正;新木 健一郎;和田 聡;柏原 賢治;細内 康男;桑野 博行, Mar. 2014, Journal of Japan Surgical Society, 115, 2
OP-027-8 胆管癌におけるKPNA2発現とgemcitabine感受性の検討(OP-027 基礎 腫瘍免疫・発癌・その他,一般演題,第114回日本外科学会定期学術集会), 塚越 真梨子;鈴木 秀樹;横堀 武彦;金 泉;渡辺 亮;久保 憲生;新木 健一郎;和田 聡;柏原 賢治;細内 康男;桑野 博行, Mar. 2014, Journal of Japan Surgical Society, 115, 2
PS-154-1 大腸癌肝転移に対する治療方針と成績(PS-154 肝 転移性肝癌-2,ポスターセッション,第114回日本外科学会定期学術集会), 久保 憲生;鈴木 秀樹;塚越 真梨子;渡辺 亮;新木 健一郎;和田 聡;堤 荘一;浅尾 高行;桑野 博行, Mar. 2014, Journal of Japan Surgical Society, 115, 2
Cholangiocarcinoma with histological findings of IgG4-related sclerosing cholangitis, Saito Fumiyoshi;Araki Kenichiro;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Ikota Hayato;Shirabe Ken;Kuwano Hiroyuki, 2016, Tando, 30, 5, 864, 869
Current status and future prospects of sarcopenia research in patients with chronic liver diseases, SHIRABE Ken;ARAKI Kenichiro;TSUKAGOSHI Mariko, 2017, Nippon Shokakibyo Gakkai Zasshi, 114, 5, 826, 833
A Saved Case of Invasive Klebsiella pneumoniae Syndrome, Yamanaka Takahiro;Shirabe Ken;Araki Kenichiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Oshima Kiyohiro;Kuwano Hiroyuki, 2017, Nihon Fukubu Kyukyu Igakkai Zasshi (Journal of Abdominal Emergency Medicine), 37, 6, 931, 934
Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection, Araki Kenichiro;Watanabe Akira;Kubo Norio;Shirabe Ken;Harimoto Norifumi;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi, 2019, The Journal of Medical Investigation, 66, 3, 319, 323
A Saved Case of Liver Abscess and Portal Vein Thrombosis, Yamanaka Takahiro;Oshima Kiyohiro;Kuwano Hiroyuki;Shirabe Ken;Araki Kenichiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Harimoto Norifumi;Shibuya Kei, 2018, Nihon Fukubu Kyukyu Igakkai Zasshi (Journal of Abdominal Emergency Medicine), 38, 7, 1189, 1193
SSI防止のための更なる工夫 肝切除症例におけるSSIの検討, ;;;;;;;;;;;, Oct. 2015, 76, 増刊, 440
コンピュータシミュレーションを用いたPostero-Superior lesionに対する腹腔鏡下肝切除, ;;;;;;;;, Oct. 2015, 76, 増刊, 521
IPMNの悪性リスク評価の検討, ;;;;;;;;;;;, Oct. 2015, 76, 増刊, 575
MEN 1型に合併した多発性ガストリノーマに対して亜全胃温存膵頭十二指腸切除を施行した1例, ;;;;;;;;;;;, Oct. 2015, 76, 増刊, 699
IgG4胆管炎を合併した胆管癌の一例, ;;;;;;, Oct. 2015, 76, 増刊, 820
高難度なPostero-Superior lesionに対する腹腔鏡下肝部分切除の手術戦略, ;;;;;;;;, Dec. 2015, 20, 7, OS35
Mini Loop Retractorを用いた腹腔鏡下胆嚢摘出術の有用性, ;;;;;;;;;, Dec. 2015, 20, 7, OS131
肝予備能不良症例に対する腹腔鏡下肝切除, ;;;;;;;;, Dec. 2015, 20, 7, OS136
尾側膵切除における自動縫合器を用いた膵切離の治療成績, ;;;;;;;, Dec. 2015, 20, 7, OS190
膵癌における細胞周期調節因子FBXW7発現の臨床病理学的意義, ;;;;;, Oct. 2015, 74回, P
胆管癌におけるNKG2Dリガンド発現と予後, ;;;;;;, Oct. 2015, 74回, P
膵液漏・胃排出遅延の克服を目指した膵頭十二指腸切除術(PD)における再建の工夫, ;;;;;;;;;;, Jun. 2016, 28回, 411
右前・後上区域に対する腹腔鏡下肝部分切除術の工夫, ;;;;;;;;;, Jun. 2016, 28回, 419
切除適応を考えたIPMN国際診療ガイドラインの有用性評価, ;;;;;;;;;;, Jun. 2016, 28回, 471
胆管拡張を伴った膵胆管合流異常症に対して、分流手術施行後に十二指腸乳頭部癌を発症した一例, ;;;;;;;;;;, Jun. 2016, 28回, 560
大腸癌肝転移切除例の検討, ;;;;;;;;;;;;, Jun. 2016, 28回, 576
胆管癌において術前D-dimer値は術後再発の予測因子となる, ;;;;;;;;;, Jun. 2016, 28回, 615
直腸NET多発肝転移に胆管系マーカー陽性の微小病変を伴った1例, ;;;;;;;;;;, Jun. 2016, 28回, 626
膵胆管合流異常の胆嚢・胆管にて、importin α1(KPNA2)発現は腫瘍細胞の増殖能と形質転換に関与する, ;;;;;;;, Jun. 2016, 28回, 647
血小板数×D-dimerは胆管癌切除後における再発・予後予測マーカーとして有用である, ;;;;;;;;;, Aug. 2016, 30, 3, 497
切除可能大腸癌肝転移における術前・術後化学療法の意義, ;;;;;;;;;, Apr. 2016, 116回, PS
膵癌におけるRAB5発現の臨床病理学的検討, ;;;;;;;;;;;, Apr. 2016, 116回, PS
肝門部領域胆管癌における、3テスラMRIおよびMD-CTでの術前進展度診断の検討, ;;;;;;, Apr. 2016, 116回, PS
膵癌における新規バイオマーカーの探索 FBXW7とその関連因子発現の意義, ;;;;;;;;, Apr. 2016, 116回, OP
術前・術中ナビゲーションを駆使した肝切除戦略と微小病変への対応について, ;;;;;;;;;, Apr. 2016, 116回, PS
肝内胆管癌におけるFDG-PET評価はリンパ節転移、術後再発の予測に有用である, ;;;;;;;, Apr. 2016, 116回, PS
局所進行膵癌に対する集学的治療 局所進行膵癌に対するGemcitabine併用重粒子線治療の有用性, ;;;;;;;;;;;;;, Apr. 2016, 116回, WS
【転移性肝腫瘍のいま-なぜ・どこが原発臓器ごとに違うのか】転移性肝腫瘍の治療 GIST肝転移, ;;;;;;, Nov. 2016, 71, 12, 1366
肝切除術におけるサルコペニアの意義, ;;;;;;;;, Oct. 2016, 77, 増刊, 461
肝流入血流遮断を最小限にする系統的肝切除術の工夫, ;;;;;;;;, Oct. 2016, 77, 増刊, 470
大腸癌両葉多発肝転移切除の治療成績と切除後再発に関与する因子について, ;;;;;;;;, Oct. 2016, 77, 増刊, 495
膵体尾部切除術における膵断端閉鎖法の検討, ;;;;;;;;, Oct. 2016, 77, 増刊, 499
腹腔鏡下肝切除におけるDifficulty scoreの有用性検証, ;;;;;;;, Oct. 2016, 77, 増刊, 520
肝離断における出血量軽減の工夫, ;;;;;;;;, Oct. 2016, 77, 増刊, 673
開腹ドレナージ術のみで軽快した外傷性IIIb(Ph)型膵損傷, ;;;;;;;, Oct. 2016, 77, 増刊, 829
閉塞性黄疸を合併した膵頭部Schwannomaの一例, ;;;;;;;;;, Oct. 2016, 77, 増刊, 1039
外科における基礎的研究 セレンディピティーを求めて 胆管癌における核-細胞質間輸送蛋白KPNA2発現制御に基づく新たな治療戦略, ;;;;;;;;;, Jul. 2016, 71回, WS7
腹腔鏡下肝切除における実行性・安全性を重視した総合戦略の検証, ;;;;;;;;;, Jul. 2016, 71回, P2
膵胆管合流異常症の前癌病変におけるタンパク質の核細胞質間輸送と細胞質内輸送に関する研究, ;;;;;;;, Jul. 2016, 71回, P2
膵管内乳頭粘液性腫瘍の悪性化におけるkaryopherin-α2発現の意義, ;;;;;;;;;, Jul. 2016, 71回, P2
膵癌進展におけるエンドソーム関連蛋白RAB5発現の意義 E-cadherin発現の関連から, ;;;;;;;;;, Jul. 2016, 71回, P2
肝悪性腫瘍の肝切除においてD-dimerは術後合併症の予測因子となり肝切除量等を反映する, ;;;;;;;;;, Jul. 2016, 71回, P3
胆管癌における予後および化学療法効果予測マーカーとしてのFBXW7発現の意義, ;;;;;;;;;, Jul. 2016, 71回, P3
IgG4関連硬化性胆管炎の組織所見を伴った下部胆管癌の1切除例, ;;;;;;;;, Dec. 2016, 30, 5, 864
侵襲性クレブシエラ感染症の1救命例, ;;;;;;;;;;;, Feb. 2017, 37, 2, 314
膵頭十二指腸切除術8年後のseptic shock、播種性血管内凝固症候群、門脈血栓、肝不全、肝動脈瘤を併発した肝膿瘍に対して集学的治療で救命しえた1例, ;;;;;;;;, Feb. 2017, 37, 2, 314
胆管癌におけるKPNA2高発現は予後不良と抗癌剤感受性に関与する, ;;;;;;;;, Oct. 2016, 75回, P
膵癌進展におけるRAB5発現の意義 E-cadherin発現との関連, ;;;;;;;;;;;, Oct. 2016, 75回, P
膵臓 膵がん治療の個別化に向けて 膵癌における新規バイオマーカーとしてのFBXW7発現の意義, ;;;;;;;;;, Oct. 2016, 54回, WS1
胆道 胆道がんの手術療法 血小板数×D-dimerは胆管癌切除後における再発・予後予測マーカーとして有用である, ;;;;;;;;;, Oct. 2016, 54回, WS40
【NAFLD/NASH;臨床と研究の最前線】肝疾患におけるサルコペニア研究の現状と今後の展開, ;;, May 2017, 114, 5, 826
【術前患者への介入がポイント がん患者への栄養管理と栄養指導】肝胆膵がん患者の病態と術前栄養管理の意義 肝胆膵がん患者における特有の栄養異常とサルコペニアを背景においた術前栄養管理の意義, ;;;, Jul. 2017, 2, 4, 31
Borderline resectable膵癌に対する集学的治療 当院における局所進行膵癌に対するGemcitabine併用重粒子線治療の有用性, ;;;;;;;;;;;;, Apr. 2017, 117回, WS
膵頭十二指腸切除(PD)術後8年後の敗血症性ショック、播種性血管内凝固症候群(DIC)と門脈血栓、肝不全、肝動脈瘤を併発した肝膿瘍に対して集学的治療を行い救命しえた1例, ;;;;;;;;;;;;, Apr. 2017, 117回, RS
集学的治療を行った巨大な破骨細胞様巨細胞型退形成膵癌の一例, ;;;;;;;;;, Apr. 2017, 117回, RS
サルコペニア症例に対する肝胆膵周術期の運動・栄養療法の効果, ;;;;;;;;;, Apr. 2017, 117回, SF
肝切除におけるEOB-MRIを用いた機能的残肝容積の意義と境界適応症例への有用性, ;;;;;;;;, Apr. 2017, 117回, SF
胸部食道癌手術症例におけるサルコペニアの評価と治療成績に関する検討, ;;;;;;;;;;;, Apr. 2017, 117回, SF
癌関連線維芽細胞を標的とした膵癌の新規治療に関する基礎的研究, ;;;;;;;;;, Apr. 2017, 117回, SF
流入血行遮断時間の短縮による肝右葉切除術後の肝再生への効果, ;;;;;;;;, Apr. 2017, 117回, PS
大腸癌肝転移切除例における術前d-dimer測定の臨床的意義, ;;;;;;;;, Apr. 2017, 117回, PS
膵嚢胞性病変切除例の検討, ;;;;;;;;;, Apr. 2017, 117回, PS
膵癌におけるFBXW7発現の臨床的意義および癌進展・治療抵抗性に与える影響, ;;;;;;;;, Jul. 2017, 72回, RS1
胆管細胞癌に対する治療戦略 腫瘤形成型胆管細胞癌における炎症因子と予後、炎症指標としてのFDG-PETの有用性に関する検討, ;;;;;;;;;, Jul. 2017, 72回, WS06
腹腔鏡下肝切除における困難症例への手技の工夫と成績 S7/8領域と再肝切除症例, ;;;;;;;;;, Jul. 2017, 72回, RS3
系統的肝切除術における出血量軽減の工夫, ;;;;;;;;, Jul. 2017, 72回, PP15
間質性肺炎を合併した患者に対する肝切除術の経験, ;;;;;;;;, Jul. 2017, 72回, PO16
サルコペニア症例に対する術前栄養療法・リハビリテーションの効果, ;;;;;;;;;, Jul. 2017, 72回, RS3
侵襲性クレブシエラ感染症の1救命例, ;;;;;;;;;, Sep. 2017, 37, 6, 931
大腸癌肝転移に対するConversion surgery 大腸癌肝転移切除に対するconversion therapyの適応決定におけるFDG-PETの意義, ;;;;;;;;;;;;;, Oct. 2017, 78, 増刊, 391
膵液漏の克服を目指した膵頭十二指腸切除術における再建の工夫, ;;;;;;;;;, Oct. 2017, 78, 増刊, 682
膵癌に対する術前化学療法の検討, ;;;;;;;;;, Oct. 2017, 78, 増刊, 703
Slow growthが特徴と考えられた小型細胆管細胞癌の1例, ;;;;;;;;;, Oct. 2017, 78, 増刊, 740
希少な肝原発の粘液癌に対して肝切除を施行した一例, ;;;;;;;;;;;;, Oct. 2017, 78, 増刊, 867
肝星細胞を標的とした肝内胆管癌の新たな治療戦略の開発, ;;;;;;;;;;, Oct. 2017, 55回, O9
膵管内乳頭粘液性腫瘍におけるkaryopherin-α2発現の意義, ;;;;;;;;;;, Oct. 2017, 55回, O26
【Borderline resectable膵癌に対する集学的治療】局所進行膵癌に対するGemcitabine併用重粒子線治療, ;;;;;;;;;;;;;;;;;, Jan. 2018, 63, 5, 455
【NASH/NAFLDの新知見】成因・病態 NASH/NAFLDにおけるサルコペニアの関与 診断評価法も含めて, ;;, Apr. 2018, 76, 4, 576
肝硬変合併肝細胞癌に対する新たな治療戦略の確立を目指して 新規バイオマーカーM2BPGiに注目して, ;;;;;;;;;;, Apr. 2018, 118回, 814
大腸癌肝転移におけるFDG-PETに基づく集学的治療戦略構築の試み, ;;;;;;;;;;;;;;;;, Apr. 2018, 118回, 1080
肝細胞癌における癌関連線維芽細胞を標的とした新たな治療の開発, ;;;;;;;;;;, Apr. 2018, 118回, 1216
肝切除後肝不全発生の正確な術前予測を目指したEOB-MRIによるFunctional remnant liver volumetryの有用性, ;;;;;;;;;;, Apr. 2018, 118回, 1225
Conophyllineは癌関連線維芽細胞の抑制を介して膵癌の進展を抑制する, ;;;;;;;;;;, Apr. 2018, 118回, 1351
脈管侵襲陽性肝細胞癌に対する手術成績, ;;;;;;;;;, Apr. 2018, 118回, 2020
膵癌免疫治療への応用にむけたメソテリン由来HLA-A24拘束性エピトープペプチドの開発, ;;;;;;;;;;;;;, May 2018, 33, 3, 471
Conophyllineを用いた癌関連線維芽細胞を標的とした膵癌の新規治療法の開発, ;;;;;;;;;;;, May 2018, 33, 3, 488
グルカゴン陽性NETへの分化が示唆される主膵管型IPMCの1切除例, ;;;;;;;;;;, May 2018, 33, 3, 571
【循環癌細胞(CTC)とリキッドバイオプシー】上皮マーカー陰性CTCの捕捉, ;;, Nov. 2018, 62, 11, 1460
【食道癌(第2版)-基礎・臨床研究の進歩-】食道癌の生物学 食道扁平上皮癌の発生機序, ;;;;;;;;;, Oct. 2018, 76, 増刊8 食道癌, 63
当科における肝切除術後合併症リスク因子の検討, ;;;;;;;;;, Jul. 2018, 73回, 41
肝切除症例におけるM2BPGiの意義, ;;;;;;;;;, Jul. 2018, 73回, 739
新たな肝切除基準を目指したEOB-MRIによるFunctional remnant liver volumetryの有用性, ;;;;;;;;;, Jul. 2018, 73回, 869
肝予備能評価の現状:手術の安全性向上のために EOB-MRIを用いたFunctional remnant liver volumetry(FRLV)による術後肝不全の正確な術前予測 肝筋肉比(LMR)、肝脾臓比(LSR)の比較検討を含めて, ;;;;;;;;;;;, Oct. 2018, 79, 増刊, 390
右肝静脈灌流域切除術におけるICG蛍光法による肝切除術中ナビゲーションの有用性について, ;;;;;;;;;;;, Oct. 2018, 79, 増刊, 450
脾臓摘出後門脈血栓症例に対する第Xa因子阻害薬(Edoxaban)の有用性の検討, ;;;;;;;;;;;, Oct. 2018, 79, 増刊, 567
下大静脈腫瘍栓を有する右副腎腫瘍を伴う径1.5cmの肝細胞癌の1例, ;;;;;;;;;;, Oct. 2018, 79, 増刊, 618
膵神経内分泌腫瘍切除症例における再発因子の検討, ;;;;;;;;;;;;;, Oct. 2018, 79, 増刊, 630
脾臓摘出後門脈血栓症例に対する治療法の検討, ;;;;;;;;, Nov. 2018, 59, Suppl.3, A972
集学的治療で救命し得た、肝膿瘍による門脈血栓症の1例, ;;;;;;;;;;;, Nov. 2018, 38, 7, 1189
肝細胞癌におけるWFA+Mac-2 binding protein(M2BPGi)のin vitro機能解析(Functional analysis of WFA+ Mac-2 Binding Protein(M2BPGi) in hepatocellular carcinoma in vitro), ;;;;;;;;;;, Sep. 2018, 77回, 392
肝星細胞を標的とした、肝硬変合併肝細胞癌に対する新規治療(New therapy for hepatocellular carcinoma with liver cirrhosis, targeted to hepatic stellate cells), ;;;;;;;;;;, Sep. 2018, 77回, 1394
大腸癌肝転移切除のD-dimerの予後予測における臨床的意義, ;;;;;;;;;, Oct. 2018, 56回, P88
癌関連線維芽細胞を標的とした肝内胆管癌の新たな治療戦略, ;;;;;;;;;;;, Oct. 2018, 56回, P90
【NAFLD/NASH-診断・治療の最新動向-】サルコペニアとNAFLD/NASH, ;;, May 2019, 77, 5, 878
前区域・内側区域の頭側領域(S8 vent、S4b)における腹腔鏡下肝切除の手技の定型化と腫瘍局在ごとの手術戦略, ;;;;;;;, Dec. 2018, 23, 7, OS184
腫瘍免疫のがん治療への応用 血清α1-酸性糖蛋白質のフコシル化に着目した肺癌における免疫チェックポイント阻害剤感受性に関する新規バイオマーカー, ;;;;;;;;, Apr. 2019, 119回, WS
肝切除におけるシミュレーション・ナビゲーションの応用 右肝静脈灌流域切除術におけるICG蛍光法による肝切除術中ナビゲーションの有用性について, ;;;;;;;;;;;, Apr. 2019, 119回, WS
膵癌におけるTenascin-C高分子バリアントおよびAnnexin-A2発現の予後マーカーとしての有用性, ;;;;;;;;;;;;;, Apr. 2019, 119回, SF
M2BPGiによる膵癌の増殖・浸潤促進の新たな分子機序の解明, ;;;;;;;;;;;;, Apr. 2019, 119回, SF
EOB-MRIを用いた機能的残肝容積による正確な術前肝予備能評価と肝切除術後肝不全の予測, ;;;;;;;;;;;, Apr. 2019, 119回, SF
褐色細胞腫に対する腹腔鏡下副腎摘出術の検討, ;;;;;;;;;;;;;;, Apr. 2019, 119回, PS
膵神経内分泌腫瘍切除症例におけるNLR(neutrophil-lymphocyte ratio)の意義に関する検討, ;;;;;;;;;;;;;;;;;;, Apr. 2019, 119回, PS
肝線維化マーカーM2BPGiに着目した肝細胞癌切除後の腹水発生予測に関する研究, ;;;;;;;;;;;, Apr. 2019, 119回, PS
膵切除におけるサルコペニアの意義, ;;;;;;;;;;;;, Apr. 2019, 119回, PS
大腸癌多発肝転移におけるFDG-PETのimaging biomarkerとしての有用性, ;;;;;;;;;, Apr. 2019, 119回, PS
肝胆膵領域における漏れない、狭窄しない吻合法 膵空腸吻合における膵液漏予防のための工夫, ;;;;;;;;;;;;, Nov. 2018, 48回, 76
PIVKA-II高値を示し、組織学的に高度な褐色顆粒の沈着を認めた分類不能型肝細胞腺腫の1例, ;;;;;;;;;;;;;, Apr. 2019, 354回, 48
膵神経内分泌腫瘍におけるNLR(neutrophil-lymphocyte ratio)の意義に関する検討, ;;;;;;;;;;;;;;;;;, Jun. 2019, 34, 3, A193
癌微小環境の制御に基づいた肝内胆管癌の新たな治療に関する研究, ;;;;;;;;;, Jul. 2019, 74回, P187
肝切除術後の離断型胆汁漏の診断と治療方針, ;;;;;;;;, Jul. 2019, 74回, RS28
大腸癌肝転移におけるFDG-PETのimaging biomarkerとしての有用性 免疫組織化学的評価における検討, ;;;;;;;;;, Jul. 2019, 74回, RS36
急速増大を認めた肝外突出型肝細胞癌切迫破裂に対して肝切除を伴う膵頭十二指腸切除術を施行した1例, ;;;;;;;;;, Jul. 2019, 74回, RS39
Frailな患者に対する消化器外科手術 膵切除における術前握力評価の意義とリハビリテーション栄養の効果, ;;;;;;;;;, Jul. 2019, 74回, WS18
脈管侵襲陽性肝細胞癌に対する手術成績, ;;;;;;;;;, Jul. 2019, 74回, P184
肝内胆管癌切除症例における18F-FDG PET/CTのSUVmaxが予後に与える影響と炎症関連スコアとの比較に関する検討, ;;;;;;;;;;;;;, Oct. 2019, 33, 3, 532
トランスレーショナルリサーチについて考える:臨床現場のアイデアをどう生かすか 新規肝線維化血清マーカーの研究から見えてきた新たな肝再生因子の発見と展開, ;;;;;;;;;;;, Oct. 2019, 80, 増刊, 360
右肝静脈灌流域切除術における肝切除術中ICG蛍光ナビゲーションの有用性について, ;;;;;;;;;;;, Oct. 2019, 80, 増刊, 474
肝切除術後の離断型胆汁漏の診断と治療方針, ;;;;;;;, Oct. 2019, 80, 増刊, 484
脈管侵襲陽性肝細胞癌に対する手術成績, ;;;;;;;;;;;, Oct. 2019, 80, 増刊, 508
大腸癌肝転移におけるFDG-PETに基づく治療戦略, ;;;;;;;;, Oct. 2019, 80, 増刊, 519
肝細胞癌・混合型肝癌に対して集学的治療を行った1例, ;;;;;;;;;;, Oct. 2019, 80, 増刊, 853
【フレイルな患者に対する消化器外科手術-術前から術後までの包括的な栄養管理をめざして】膵切除における術前握力評価の意義とリハビリテーション栄養の効果, 塚越 真梨子, Jan. 2020, 136, 1, 79
大腸癌肝転移conversion surgeryにおけるSUV変化率に基づいた治療戦略, ;;;;;;;;;;;;, Oct. 2019, 57回, RT21
癌関連線維芽細胞の制御に基づいた肝細胞癌の新規治療の開発, ;;;;;;;;;;;;, Oct. 2019, 57回, O67
高度門脈腫瘍栓合併肝細胞癌に対するEOB-MRIによる機能的残肝予備能評価の有用性, ;;;;;;;;;;;, Oct. 2019, 57回, O67
膵神経内分泌腫瘍におけるバイオマーカーとしての好中球リンパ球比の意義, ;;;;;;;;;;;;;, Oct. 2019, 57回, P27
Fas/FasLシグナルは腫瘍免疫応答での抗原特異的疲弊化CD8T細胞の生存に必須である, ;;;;;;;;;, Oct. 2019, 57回, P113
腹腔鏡下肝切除におけるICG蛍光ガイドによる区域間同定の有用性, ;;;;;;;;;, Dec. 2019, 24, 7, SF010
腹腔鏡下再肝切除におけるhanging methodを用いた出血コントロールの工夫, ;;;;;;;;;, Dec. 2019, 24, 7, MO065
腹腔鏡下胆嚢摘出術による肝門部胆管・右肝動脈の合併損傷に対して肝右葉切除を施行した1例, ;;;;;;;;;, Apr. 2020, 45, 2, 134
癌関連線維芽細胞の制御による、肝内胆管癌の新たな治療戦略, ;;;;;;;;;;;;, Nov. 2019, 116, 臨増大会, A851
正中弓状靱帯圧迫症候群を伴う下膵十二指腸動脈瘤に対して弓状靱帯切開術とIVR治療を施行した2例, ;;;;;;;;;;;;;;, Feb. 2020, 40, 2, 368
外科切除により診断し得た膵管内管状乳頭腫瘍の1例, ;;;;;;;;;, May 2020, 359回, 29
がん周術期栄養管理は短期成績・長期予後を改善するか 膵頭十二指腸切除術における骨格筋量評価に基づいた周術期栄養管理, ;;;;;;;;;, Aug. 2020, 120回, PD
新規肝線維化血清マーカーの研究により見つかった新たな肝再生因子の発見と展開, ;;;;;;;;;;;, Aug. 2020, 120回, SF
肝切除におけるEOB-MRIを用いたFunctional remnant liver volumetryによる肝臓関連合併症の予測と手術適応への応用について, ;;;;;;;;;;;, Aug. 2020, 120回, SF
肝細胞癌の免疫チェックポイント(B7 family)発現におけるCMTM6発現の意義, ;;;;;;;;;;;, Aug. 2020, 120回, SF
手術によらずに抜去可能なスペーサーの開発, ;;;;;;;;;;, Aug. 2020, 120回, DP
癌関連線維芽細胞が産生するサイトカインの制御に基づく、肝癌の新たな治療戦略, ;;;;;;;;;;;;, Aug. 2020, 120回, DP
脈管侵襲陽性肝細胞癌に対する手術成績, ;;;;;;;;;;;, Aug. 2020, 120回, DP
肝切除における胆汁漏のリスク因子に関する検討, ;;;;;;;;;;, Aug. 2020, 120回, DP
肝前区域門脈の走行に関する検討, ;;;;;;;;;;;, Aug. 2020, 120回, DP
Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases., Suzuki Hideki;Fujii Takaaki;Asao Takayuki;Tsutsumi Soichi;Wada Satoshi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Tsukagoshi Mariko;Kuwano Hiroyuki, World journal of surgery, 38, 8
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma., Watanabe Akira;Suzuki Hideki;Yokobori Takehiko;Tsukagoshi Mariko;Altan Bolag;Kubo Norio;Suzuki Shigemasa;Araki Kenichiro;Wada Satoshi;Kashiwabara Kenji;Hosouchi Yasuo;Kuwano Hiroyuki, 27 May 2014, Cancer science, 105, 6
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma., Suzuki Hideki;Komuta Mina;Bolog Altan;Yokobori Takehiko;Wada Satoshi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Tsukagoshi Mariko;Kuwano Hiroyuki, 27 Mar. 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 47, 7
Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer., Suzuki Hideki;Wada Satoshi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Tsukagoshi Mariko;Kuwano Hiroyuki, World journal of gastroenterology, 21, 35
Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case., Ishii Norihiro;Suzuki Hideki;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Araki Kenichiro;Wada Satoshi;Kuwano Hiroyuki, International surgery, 100, 6
Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma., Tsukagoshi Mariko;Wada Satoshi;Yokobori Takehiko;Altan Bolag;Ishii Norihiro;Watanabe Akira;Kubo Norio;Saito Fumiyoshi;Araki Kenichiro;Suzuki Hideki;Hosouchi Yasuo;Kuwano Hiroyuki, 02 Feb. 2016, Cancer science, 107, 2
High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction., Saito Fumiyoshi;Araki Kenichiro;Yokobori Takehiko;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Altan Bolag;Shirabe Ken;Kuwano Hiroyuki, 23 Jun. 2016, Journal of surgical oncology, 114, 4
A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma., Watanabe Akira;Araki Kenichiro;Hirai Keitarou;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Hoshino Kouki;Kuwano Hiroyuki;Shirabe Ken, 21 Jul. 2016, Annals of surgical oncology, 23, Suppl 5
Neuroendocrine tumor of the ampulla of Vater with distant cystic lymph node metastasis: a case report., Tsukagoshi Mariko;Hosouchi Yasuo;Araki Kenichiro;Mochida Yasushi;Aihara Ryusuke;Shirabe Ken;Kuwano Hiroyuki, 25 Jul. 2016, Surgical case reports, 2, 1
Presence of Cytokeratin 19-Expressing Cholangiocarcinoma-Like Tumour in a Liver Metastatic Lesion of Rectal Neuroendocrine Tumour., Ishii Norihiro;Araki Kenichiro;Yokobori Takehiko;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Hirai Keitaro;Shirabe Ken;Kuwano Hiroyuki, 12 Aug. 2016, Case reports in gastroenterology, 10, 2
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression., Igarashi Takamichi;Araki Kenichiro;Yokobori Takehiko;Altan Bolag;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Handa Tadashi;Hosouchi Yasuo;Nishiyama Masahiko;Oyama Tetsunari;Shirabe Ken;Kuwano Hiroyuki, Oncotarget, 8, 7
Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins., Tsukagoshi Mariko;Araki Kenichiro;Yokobori Takehiko;Altan Bolag;Suzuki Hideki;Kubo Norio;Watanabe Akira;Ishii Norihiro;Hosouchi Yasuo;Nishiyama Masahiko;Shirabe Ken;Kuwano Hiroyuki, Oncotarget, 8, 26
Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review., Kubo Norio;Araki Kenichiro;Yamanaka Takahiro;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Hirai Keitaro;Saitoh Fumiyoshi;Kuwano Hiroyuki;Shirabe Ken, 01 Mar. 2017, Surgery today, 47, 10
Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms., Watanabe Akira;Araki Kenichiro;Yokobori Takehiko;Altan Bolag;Ishii Norihiro;Tsukagoshi Mariko;Kubo Norio;Saito Fumiyoshi;Suzuki Hideki;Kuwano Hiroyuki, 17 Jan. 2017, Oncology letters, 13, 3
Enhanced karyopherin-α2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms., Kubo Norio;Araki Kenichiro;Altan Bolag;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kato Toshihide;Hirai Keitaro;Yokobori Takehiko;Saito Fumiyoshi;Suzuki Hideki;Kuwano Hiroyuki;Shirabe Ken, 23 Apr. 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 17, 4
Current status and future prospects of sarcopenia research in patients with chronic liver diseases., Shirabe Ken;Araki Kenichiro;Tsukagoshi Mariko, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 114, 5
Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy., Ishii Norihiro;Araki Kenichiro;Yokobori Takehiko;Watanabe Akira;Tsukagoshi Mariko;Kubo Norio;Suzuki Hideki;Saito Fumiyoshi;Altan Bolag;Hosouchi Yasuo;Shirabe Ken;Kuwano Hiroyuki, 29 Mar. 2017, Oncology letters, 13, 5
Carcinoma of the Papilla of Vater after Diversion Operation for Pancreaticobiliary Maljunction., Yamanaka Takahiro;Araki Kenichiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Kuwano Hiroyuki;Shirabe Ken, 17 May 2017, Case reports in gastroenterology, 11, 2
Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms., Tsukagoshi Mariko;Araki Kenichiro;Saito Fumiyoshi;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Ishii Norihiro;Yamanaka Takahiro;Shirabe Ken;Kuwano Hiroyuki, 30 Jun. 2017, Digestive diseases and sciences, 63, 4
Small cholangiolocellular carcinoma that was difficult to distinguish from cholangiocellular carcinoma: a case report., Ishii Norihiro;Araki Kenichiro;Yamanaka Takahiro;Handa Tadashi;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Aishima Shinichi;Kuwano Hiroyuki;Shirabe Ken, 15 Sep. 2017, Surgical case reports, 3, 1
Internal Hernia into the Treitz Fossa after Pancreaticoduodenectomy., Yamanaka Takahiro;Araki Kenichiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Kuwano Hiroyuki;Shirabe Ken, 30 Oct. 2017, Case reports in gastroenterology, 11, 3
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1., Ishii Norihiro;Araki Kenichiro;Yokobori Takehiko;Gantumur Dorgormaa;Yamanaka Takahiro;Altan Bolag;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Hosouchi Yasuo;Kuwano Hiroyuki;Shirabe Ken, 06 Nov. 2017, Oncotarget, 8, 68
High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer., Suzuki Kazunobu;Watanabe Akira;Araki Kenichiro;Yokobori Takehiko;Harimoto Norihumi;Gantumur Dorgormaa;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Kubo Norio;Gombodorj Navchaa;Nishiyama Masahiko;Hosouchi Yasuo;Kuwano Hiroyuki;Shirabe Ken, Anticancer research, 38, 2
Left Lobe Mobilization Strategy of Right-Sided Major Hepatectomy for Treatment of a Tumor Causing Severe Inferior Vena Cava Compression: A Novel Strategy Using the Modified Liver-Hanging Maneuver., Araki Kenichiro;Kubo Norio;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kuwano Hiroyuki;Shirabe Ken, 14 Feb. 2018, Annals of surgical oncology, 25, 5
High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma., Shimoda Yuki;Ubukata Yasunari;Handa Tadashi;Yokobori Takehiko;Watanabe Takayoshi;Gantumur Dolgormaa;Hagiwara Kei;Yamanaka Takahiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Harimoto Norifumi;Katayama Ayaka;Hikino Toshiaki;Sano Takaaki;Ogata Kyoichi;Kuwano Hiroyuki;Shirabe Ken;Oyama Tetsunari, 25 May 2018, BMC cancer, 18, 1
Successful treatment of isolated bile leakage after hepatectomy combination therapy with percutaneous transhepatic portal embolization and bile duct ablation with ethanol: a case report., Kubo Norio;Harimoto Norifumi;Shibuya Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Araki Kenichiro;Miyazaki Masaya;Kuwano Hiroyuki;Shirabe Ken, 19 Jun. 2018, Surgical case reports, 4, 1
Skeletal Muscle Volume and Intramuscular Adipose Tissue Are Prognostic Predictors of Postoperative Complications After Hepatic Resection., Harimoto Norifumi;Hoshino Hiroki;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichirou;Shirabe Ken, Anticancer research, 38, 8
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer., Tsukagoshi Mariko;Wada Satoshi;Hirono Seiko;Yoshida Shintaro;Yada Erica;Sasada Tetsuro;Shirabe Ken;Kuwano Hiroyuki;Yamaue Hiroki, 31 Jul. 2018, Oncotarget, 9, 59
The Feature of Solitary Small Nodular Type of Hepatic Epithelioid Hemangioendothelioma., Kubo Norio;Harimoto Norifumi;Araki Kenichiro;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Miyazaki Masaya;Yokoo Hideaki;Kuwano Hiroyuki;Shirabe Ken, 21 Aug. 2018, Case reports in gastroenterology, 12, 2
Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts., Ishii Norihiro;Araki Kenichiro;Yokobori Takehiko;Hagiwara Kei;Gantumur Dorgormaa;Yamanaka Takahiro;Handa Tadashi;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Harimoto Norifumi;Masamune Atsushi;Umezawa Kazuo;Kuwano Hiroyuki;Shirabe Ken, 13 Dec. 2018, Cancer science, 110, 1
Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma., Watanabe Akira;Harimoto Norihumi;Araki Kenichiro;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Yamanaka Takahiro;Yoshizumi Tomoharu;Shirabe Ken, Anticancer research, 39, 2
Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma., Harimoto Norifumi;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichirou;Tomonaga Hiroyasu;Higuchi Tetsuya;Tsushima Yoshito;Shirabe Ken, Anticancer research, 39, 2
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma., Iijima Misaki;Yokobori Takehiko;Mogi Akira;Shimizu Kimihiro;Yajima Toshiki;Kosaka Takayuki;Ohtaki Yoichi;Obayashi Kai;Nakazawa Seshiru;Gombodorj Navchaa;Tsukagoshi Mariko;Shirabe Ken;Kuwano Hiroyuki, 28 Mar. 2019, Annals of surgical oncology, 26, 6
Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report., Hoshino Kouki;Harimoto Norifumi;Muranushi Ryo;Araki Kenichiro;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Yokobori Takehiko;Shirabe Ken, 10 Apr. 2019, Surgical case reports, 5, 1
Hepatic pleomorphic leiomyosarcoma after surgery for gastric gastrointestinal stromal tumor: a case report., Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Harimoto Norifumi;Ikota Hayato;Shibuya Kei;Miyazaki Masaya;Shirabe Ken, 16 Apr. 2019, Surgical case reports, 5, 1
Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm., Igarashi Takamichi;Harimoto Norifumi;Nobusawa Sumihito;Yoshida Yuka;Yamanaka Takahiro;Hagiwara Kei;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Araki Kenichiro;Yokobori Takehiko;Yokoo Hideaki;Shirabe Ken, Pancreas, 48, 5
Complete resection of a huge pancreatic undifferentiated carcinoma with osteoclast-like giant cells., Yazawa Tomohiro;Watanabe Akira;Araki Kenichiro;Segawa Atsuki;Hirai Keitaro;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Hoshino Kouki;Kuwano Hiroyuki;Shirabe Ken, 01 Aug. 2017, International cancer conference journal, 6, 4
Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor., Harimoto Norifumi;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichirou;Hosouchi Yasuo;Suzuki Hideki;Arakawa Kazuhisa;Hirai Keitarou;Fukazawa Takaharu;Ikota Hayato;Shirabe Ken, Pancreas, 48, 7
Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma., Ishii Norihiro;Harimoto Norifumi;Araki Kenichiro;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Gantumur Dolgormaa;Yamanaka Takahiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Shirabe Ken, 09 Aug. 2019, Hepatology research : the official journal of the Japan Society of Hepatology, 49, 12
Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages., Harimoto Norifumi;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichirou;Hosouchi Yasuo;Suzuki Hideki;Arakawa Kazuhisa;Hirai Keitarou;Fukazawa Takaharu;Ikota Hayato;Shirabe Ken, 07 Aug. 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 19, 6
High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer., Hagiwara Kei;Harimoto Norifumi;Yokobori Takehiko;Muranushi Ryo;Hoshino Kouki;Gantumur Dorgormaa;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Hosouchi Yasuo;Shirabe Ken, 28 Aug. 2019, Annals of surgical oncology, 27, 3
Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection., Araki Kenichiro;Harimoto Norifumi;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shirabe Ken, 29 Aug. 2019, Asian journal of endoscopic surgery, 13, 3
Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment., Araki Kenichiro;Harimoto Norifumi;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Tsushima Yoshito;Shirabe Ken, 30 Aug. 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association, 22, 2
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors., Nakazawa Nobuhiro;Yokobori Takehiko;Kaira Kyoichi;Turtoi Andrei;Baatar Seded;Gombodorj Navchaa;Handa Tadashi;Tsukagoshi Mariko;Ubukata Yasunari;Kimura Akiharu;Kogure Norimichi;Ogata Kyoichi;Maeno Toshitaka;Sohda Makoto;Yajima Toshiki;Shimizu Kimihiro;Mogi Akira;Kuwano Hiroyuki;Saeki Hiroshi;Shirabe Ken, 30 Sep. 2019, Annals of surgical oncology, 27, 3
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis., Watanabe Akira;Harimoto Norifumi;Yokobori Takehiko;Araki Kenichiro;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Yamanaka Takahiro;Handa Tadashi;Oyama Tetsunari;Higuchi Tetsuya;Shirabe Ken, 14 Oct. 2019, International journal of clinical oncology, 25, 2
Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection., Araki Kenichiro;Harimoto Norifumi;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shirabe Ken, The journal of medical investigation : JMI, 66, 3.4
Albumin-Indocyanine Green Evaluation (ALICE) grade predicts bile leakage after hepatic resection., Harimoto Norifumi;Muranushi Ryo;Hoshino Kouki;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Shirabe Ken, 14 Jan. 2020, Surgery today, 50, 8
Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts., Yamanaka Takahiro;Harimoto Norifumi;Yokobori Takehiko;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Gantumur Dolgormaa;Handa Tadashi;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Shirabe Ken, 04 Feb. 2020, British journal of cancer, 122, 7
Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer., Tsukagoshi Mariko;Yokobori Takehiko;Yajima Toshiki;Maeno Toshitaka;Shimizu Kimihiro;Mogi Akira;Araki Kenichiro;Harimoto Norifumi;Shirabe Ken;Kaira Kyoichi, Medicine, 99, 7
Hepatic resection for the right hepatic vein drainage area with indocyanine green fluorescent imaging navigation., Kubo Norio;Araki Kenichiro;Harimoto Norifumi;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Shirabe Ken, 17 Mar. 2020, Journal of hepato-biliary-pancreatic sciences, 27, 7
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma., Togo Maria;Yokobori Takehiko;Shimizu Kimihiro;Handa Tadashi;Kaira Kyoichi;Sano Takaaki;Tsukagoshi Mariko;Higuchi Tetsuya;Yokoo Satoshi;Shirabe Ken;Oyama Tetsunari, 02 Apr. 2020, British journal of cancer, 122, 11
Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report., Hoshino Kouki;Harimoto Norifumi;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Tomomasa Ran;Nobusawa Sumihito;Aishima Shinichi;Nakashima Osamu;Shirabe Ken, 07 May 2020, Surgical case reports, 6, 1
Rare metastatic pancreatic tumors from lung cancer with cystic changes resembling intraductal papillary mucinous neoplasm: a case report., Watanabe Akira;Harimoto Norifumi;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Kubo Norio;Araki Kenichiro;Suzuki Aya;Hara Kenichiro;Shirabe Ken, 28 May 2020, Surgical case reports, 6, 1
Liver metastasis from papillary thyroid carcinoma treated by laparoscopic hepatectomy 43 years after resection of the primary tumor: a case report., Tsukagoshi Mariko;Harimoto Norifumi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Ishii Norihiro;Yajima Toshiki;Sano Takaaki;Shirabe Ken, 18 Jun. 2020, Surgical case reports, 6, 1
Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus., Araki Kenichiro;Harimoto Norifumi;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Tsushima Yoshito;Shirabe Ken, 01 Jul. 2020, Surgery today, 50, 11
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling., Dolgormaa Gantumur;Harimoto Norifumi;Ishii Norihiro;Yamanaka Takahiro;Hagiwara Kei;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Handa Tadashi;Yokobori Takehiko;Oyama Tetsunari;Kuwano Hiroyuki;Shirabe Ken, 06 Jul. 2020, British journal of cancer, 123, 7
Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma., Harimoto Norifumi;Araki Kenichiro;Ishii Norihiro;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shirabe Ken, Anticancer research, 40, 8
Association between intraoperative and postoperative epidural or intravenous patient-controlled analgesia and pancreatic fistula after distal pancreatectomy., Igarashi Takamichi;Harimoto Norifumi;Matsui Yusuke;Muranushi Ryo;Yamanaka Takahiro;Hagiwara Kei;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Araki Kenichiro;Saito Shigeru;Shirabe Ken, 30 Jul. 2020, Surgery today
Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report., Harimoto Norifumi;Araki Kenichiro;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shibuya Kei;Miyazaki Masaya;Kawanaka Hirofumi;Shirabe Ken, 31 Jul. 2020, Surgical case reports, 6, 1
Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors., Harimoto Norifumi;Araki Kenichiro;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Tomonaga Hiroyasu;Higuchi Tetsuya;Tsushima Yoshito;Ikota Hayato;Shirabe Ken, 14 Aug. 2020, World journal of surgery
Development of useful mice model to analyze the exhaustion mechanism of Antigen-specific CD8+T cells, Hoshino, Kouki;Yajima, Toshiki;Muranushi, Ryo;Kuriyama, Kengo;Tsukagoshi, Mariko;Shirabe, Ken, 2021, CANCER SCIENCE, 112, 407, 407
The significance of CMTM6 expression in hepatocellular carcinoma immunocheckpoint (B7 family) expression., Muranushi, Ryo;Yokobori, Takehiko;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Araki, Kenichiro;Shirabe, Ken, 2021, CANCER SCIENCE, 112, 487, 487
Hepatic stellate cell as a Mac-2-binding protein-producing cell in patients with liver fibrosis, Gantumur, Dolgormaa;Harimoto, Norifumi;Muranushi, Ryo;Hoshino, Kouki;Batbayar, Chingun;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Yokobori, Takehiko;Aishima, Shinichi;Shirabe, Ken, 2021, HEPATOLOGY RESEARCH, 51, 10, 1058, 1063
FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis, Watanabe, Akira;Harimoto, Norifumi;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Hirai, Keitaro;Tanaka, Hiroshi;Mochida, Yasushi;Kogure, Norimichi;Higuchi, Tetsuya;Shirabe, Ken, 2021, JOURNAL OF SURGICAL ONCOLOGY, 124, 3, 317, 323
Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68, Yamanaka, Takahiro;Harimoto, Norifumi;Yokobori, Takehiko;Muranushi, Ryo;Hoshino, Kouki;Hagiwara, Kei;Gantumur, Dolgormaa;Handa, Tadashi;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Umezawa, Kazuo;Shirabe, Ken, 2021, MOLECULAR CANCER THERAPEUTICS, 20, 6, 1019, 1028
Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy, Tsukagoshi, Mariko;Harimoto, Norifumi;Araki, Kenichiro;Kubo, Norio;Watanabe, Akira;Igarashi, Takamichi;Ishii, Norihiro;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Muranushi, Ryo;Yajima, Toshiki;Wada, Naoki;Shirabe, Ken, 2021, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26, 9, 1698, 1706
High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence, Muranushi, Ryo;Araki, Kenichiro;Yokobori, Takehiko;Chingunjav, Batbayar;Hoshino, Kouki;Dolgormaa, Gantumur;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Harimoto, Norifumi;Shimoda, Yuki;Sano, Rie;Oyama, Tetsunari;Saeki, Hiroshi;Shirabe, Ken, 2021, CANCER SCIENCE, 112, 8, 3314, 3323
Gastrectomy history as a predictor of post-hepatectomy complications, Harimoto, Norifumi;Araki, Kenichiro;Hagiwara, Kei;Yamanaka, Takahiro;Ishii, Norihiro;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Shirabe, Ken, 2022, SURGERY TODAY, 52, 3, 494, 501
Direct Bilirubin in Drainage Fluid 3 days after Hepatectomy Is Useful for Detecting Severe Bile Leakage, Harimoto, Norifumi;Araki, Kenichiro;Yamanaka, Takahiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Shirabe, Ken, 2022, EUROPEAN SURGICAL RESEARCH, 63, 1, 33, 39
Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy, Tsukagoshi, Mariko;Harimoto, Norifumi;Araki, Kenichiro;Kubo, Norio;Watanabe, Akira;Igarashi, Takamichi;Ishii, Norihiro;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Muranushi, Ryo;Yajima, Toshiki;Shirabe, Ken, 2021, CANCERS, 13, 16
Does intraoperative and postoperative analgesia cause bile leakage after hepatectomy?, Igarashi, Takamichi;Harimoto, Norifumi;Muranushi, Ryo;Yamanaka, Takahiro;Hagiwara, Kei;Hoshino, Kouki;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Kubo, Norio;Araki, Kenichiro;Saito, Shigeru;Shirabe, Ken, 2022, SURGERY TODAY, 52, 4, 690, 696
Significance of zinc deficiency in patients with hepatocellular carcinoma undergoing hepatic resection, Harimoto, Norifumi;Araki, Kenichiro;Muranushi, Ryo;Hoshino, Kouki;Yamanaka, Takahiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Shirabe, Ken, 2022, HEPATOLOGY RESEARCH, 52, 2, 210, 220
Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response, Harimoto, Norifumi;Itoh, Shinji;Yamanaka, Takahiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Araki, Kenichiro;Yoshizumi, Tomoharu;Shirabe, Ken, 2022, ANTICANCER RESEARCH, 42, 1, 245, 251
Prediction with functional liver volume assessment to achieve the resection limit after portal vein embolization in patients scheduled major hepatectomy, Araki, Kenichiro;Harimoto, Norifumi;Shibuya, Kei;Kubo, Norio;Watanabe, Akira;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Tsushima, Yoshito;Shirabe, Ken, 2022, HPB, 24, 2, 176, 182
Study on the portal ramification pattern of the right anterior sector of the liver and a unique medial branch (PV8c) of the right anterior portal vein, Ishii, Norihiro;Harimoto, Norifumi;Kogure, Kimitaka;Araki, Kenichiro;Hagiwara, Kei;Tsukagoshi, Mariko;Igarashi, Takamichi;Watanabe, Akira;Kubo, Norio;Shirabe, Ken, 2022, ANNALS OF GASTROENTEROLOGICAL SURGERY, 6, 5, 679, 687
The ratio of creatinine and cystatin C estimated glomerular filtration rates as a surrogate marker in patients with hepatocellular carcinoma undergoing hepatic resection, Harimoto, Norifumi;Araki, Kenichiro;Yamanaka, Takahiro;Hagiwara, Kei;Ishii, Norihiro;Tsukagoshi, Mariko;Watanabe, Akira;Takizawa, Makiko;Yokobori, Takehiko;Shirabe, Ken, 2022, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 29, 9, 964, 973
A new liver regeneration molecular mechanism involving hepatic stellate cells, Kupffer cells, and glucose-regulated protein 78 as a new hepatotrophic factor, Hagiwara, Kei;Harimoto, Norifumi;Yamanaka, Takahiro;Ishii, Norihiro;Yokobori, Takehiko;Tsukagoshi, Mariko;Watanabe, Akira;Araki, Kenichiro;Yoshizumi, Tomoharu;Shirabe, Ken, 2023, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 30, 2, 165, 176
A prospective study of sequential hepatic vein embolization after portal vein embolization in patients scheduled for right-sided major hepatectomy: Results of feasibility and surgical strategy using functional liver assessment, Araki, Kenichiro;Shibuya, Kei;Harimoto, Norifumi;Watanabe, Akira;Tsukagoshi, Mariko;Ishii, Norihiro;Ikota, Hayato;Yokobori, Takehiko;Tsushima, Yoshito;Shirabe, Ken, 2023, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 30, 1, 91, 101
Abdominal aortic calcification volume (AACV) is a predictive factor for postoperative complications associated with biliary tract cancer, Watanabe, Akira;Harimoto, Norifumi;Araki, Kenichiro;Tsukagoshi, Mariko;Ishii, Norihiro;Hagiwara, Kei;Yamanaka, Takahiro;Hoshino, Kouki;Muranushi, Ryo;Shirabe, Ken, 2023, SURGERY TODAY, 53, 2, 207, 213
Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy, Yamanaka, T. A. K. A. H. I. R. O.;Harimoto, N. O. R. I. F. U. M. I.;Muranushi, R. Y. O.;Hoshino, K. O. U. K., I;Hagiwara, K. E., I;Ishii, N. O. R. I. H. I. R. O.;Tsukagoshi, M. A. R. I. K. O.;Watanabe, A. K. I. R. A.;Araki, K. E. N. I. C. H. I. R. O.;Shirabe, K. E. N., 2022, ANTICANCER RESEARCH, 42, 12, 5971, 5976
Autotaxin is a novel surrogate marker for oxaliplatin-related sinusoidal obstruction syndrome in patients with colorectal liver metastasis, Ishii, Norihiro;Harimoto, Norifumi;Seki, Takaomi;Muranushi, Ryo;Hagiwara, Kei;Tsukagoshi, Mariko;Watanabe, Akira;Yoshida, Yuka;Araki, Kenichiro;Shirabe, Ken, 2023, HEPATOLOGY RESEARCH, 53, 8, 761, 770
Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators, Araki, Kenichiro;Harimoto, Norifumi;Shibuya, Kei;Watanabe, Akira;Tsukagoshi, Mariko;Ishii, Norihiro;Hagiwara, Kei;Muranushi, Ryo;Hoshino, Kouki;Seki, Takaomi;Shirabe, Ken, 2023, ANTICANCER RESEARCH, 43, 1, 209, 216
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer, Batbayar, Chingunjav;Ishii, Norihiro;Harimoto, Norifumi;Yokobori, Takehiko;Saito, Hideyuki;Gantumur, Dolgormaa;Gombodorj, Navchaa;Erkhem-Ochir, Bilguun;Muranushi, Ryo;Hoshino, Kouki;Yamanaka, Takahiro;Hagiwara, Kei;Tsukagoshi, Mariko;Watanabe, Akira;Araki, Kenichiro;Hosouchi, Yasuo;Shirabe, Ken, 2023, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28, 7, 901, 912
Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer, Tsukagoshi, Mariko;Watanabe, Akira;Araki, Kenichiro;Ishii, Norihiro;Hagiwara, Kei;Hoshino, Kouki;Muranushi, Ryo;Harimoto, Norifumi;Takizawa, Makiko;Shirabe, Ken, 2023, ANNALS OF GASTROENTEROLOGICAL SURGERY, 7, 5, 784, 792
Laparoscopic Liver Resection Procedure Attenuates Organ-space Surgical Site Infection Compared With Open Procedure: A Propensity Score-matched Analysis, Araki, Kenichiro;Harimoto, Norifumi;Watanabe, Akira;Tsukagoshi, Mariko;Ishii, Norihiro;Hagiwara, Kei;Muranushi, Ryo;Hoshino, Kouki;Seki, Takaomi;Shirabe, Ken, 2023, ANTICANCER RESEARCH, 43, 5, 2273, 2280
Hyperthermia/chemotherapy sensitizing strategy by targeting HIKESHI in refractory pancreatic cancer, Yokobori, Takehiko;Asao, Takayuki;Hoshino, Kouki;Muranushi, Ryo;Ishii, Norihiro;Tsukagoshi, Mariko;Araki, Kenichiro;Kuwano, Hiroyuki;Saeki, Hiroshi;Shirabe, Ken, 2023, CANCER SCIENCE, 114, 1932, 1932
Significance of malnutrition defined with Global Leadership Initiative on Malnutrition criteria in patients with hepatocellular carcinoma after hepatic resection, Harimoto, Norifumi;Tsukagoshi, Mariko;Okuyama, Takayuki;Hoshino, Kouki;Hagiwara, Kei;Kawai, Shunsuke;Ishii, Norihiro;Igarashi, Takamichi;Araki, Kenichiro;Shirabe, Ken, 2023, HEPATOLOGY RESEARCH
A case of cholangiocarcinoma complicating liver abscess-related tumor thrombus extending via the inferior vena cava to the right ventricle and visualized on transthoracic echocardiography, Kato, Toshimitsu;Yanagisawa, Kunio;Okada, Kenya;Tsukagoshi, Mariko;Tokue, Yutaka;Shirabe, Ken;Tsushima, Yoshito, 2023, JOURNAL OF MEDICAL ULTRASONICS
先天性胆道拡張症に対して総胆管空腸吻合術47 年後に肝門部胆管 癌を発症した一例, ;;;;;;;;, 2020, Annual Meeting of Japanese Study Group on Pancreaticobiliary Maljunction, 43, 0, 76, 76
Report of a Case Requiring Right Hepatectomy for Bile Duct Injury Complicating Right Hepatic Artery Injury Caused during Laparoscopic Cholecystectomy, Okuyama Takayuki;Araki Kenichiro;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Harimoto Norifumi;Shirabe Ken, 2020, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons), 45, 2, 134, 139
術前化学療法が有効であったAFP産生胆嚢癌の1切除例, ;;;;;;;;;;;, Aug. 2020, 34, 3, 514
Frail患者に対する治療方針(肝胆膵) 膵頭十二指腸切除術におけるプレハビリテーション栄養の実践, ;;;;;;;;;;;;, Oct. 2020, 81, 増刊, 267
巨大肝細胞腺腫の一切除例, ;;;;;;;;;;;;, Oct. 2020, 81, 増刊, 446
胃GIST切除後に発生した肝原発多形型平滑筋肉腫の一例, ;;;;;;;;;;, Oct. 2020, 81, 増刊, 453
肺や肝臓の微小転移を切除することで長期生存が得られた膵臓癌の2例, ;;;;;;;;;;;;;, Oct. 2020, 81, 増刊, 465
硬膜外麻酔およびIV-PCA使用と膵体尾部切除術後膵液瘻との関連, ;;;;;;;;;;;, Oct. 2020, 81, 増刊, 470
先天性胆道拡張症に対して総胆管空腸吻合術47年後に肝門部胆管癌を発症した一例, ;;;;;;;;, Nov. 2020, 43, 76
肝細胞癌切除患者における術後急性腎不全の予測因子, ;;;;;;;;;;;, Dec. 2020, 45, 5, 641
膵がんの治療戦略 膵管内乳頭粘液性腫瘍の癌化に関連する術前診断マーカー, ;;;;;;;;;;;, Oct. 2020, 58回, WS27
2cm以下膵神経内分泌腫瘍切除における予後因子の検討, ;;;;;;;;;;;;;, Oct. 2020, 58回, O29
【肝・胆道系症候群(第3版)-その他の肝・胆道系疾患を含めて-肝臓編(下)】肝腫瘍 肝内胆管癌(腺癌以外の特殊型) 肝内胆管肉腫様癌, ;, Feb. 2021, 別冊, 肝・胆道系症候群II, 176
免疫チェックポイント阻害薬の基礎 抗原特異的CD8T細胞の疲弊化誘導における各免疫チェックポイント分子の役割解明, ;;;;, Oct. 2020, 60, 6, 487
抗原特異的CD8+T細胞の疲弊化誘導メカニズムを解明するマウス腫瘍モデルの確立, ;;;;;, Oct. 2020, 79回, OJ12
肝細胞癌におけるCMTM6発現の意義, ;;;;;;;;, Oct. 2020, 79回, OJ14
高度門脈腫瘍栓合併肝細胞癌に対する機能的残肝容積(FRLV)を用いた切除戦略, ;;;;;;;;;, Dec. 2020, 75回, RS15
肝細胞癌の免疫チェックポイント(B7 family)発現におけるCMTM6発現の意義, ;;;;;;;;;, Dec. 2020, 75回, P220
新規肝線維化血清マーカーの研究により発見された新たな肝再生因子, ;;;;;;;;;, Dec. 2020, 75回, P221
C型肝炎を背景とした肝細胞癌術後の腹水発生因子の検討, ;;;;;;;;, Dec. 2020, 75回, P228
膵癌におけるD-dimerの切除後予後予測マーカーとしての意義, ;;;;;;;;, Dec. 2020, 75回, P293
膵頭十二指腸切除術に対する周術期リハビリテーション栄養の有用性, ;;;;;;;;;, Dec. 2020, 75回, P310
ICG蛍光法を用いた右肝静脈還流域切除術, ;;;;;;;;;;, Nov. 2018, 51, Suppl.2, 247
胆管腺筋腫症の一切除例, ;;;;;;;;;;;;, Apr. 2021, 82, 4, 813
超高齢者における肝切除術の治療成績に関する検討, ;;;;;;;;;;;;, Nov. 2019, 52, Suppl.2, 116
EOB-MRIを用いた機能的残肝容積による肝切除術後肝不全予測と門脈塞栓後の分肝機能評価の有用性, ;;;;;;;;;;;, Nov. 2019, 52, Suppl.2, 255
【令和時代における「尾状葉」のすべて】外科治療 肝細胞癌に対する腹腔鏡下肝切除 尾状葉病変への適応と手術手技, ;;;;;;;, May 2021, 82, 5, 689
肝細胞癌切除患者における線維化の術前評価と術後成績に関する検討, ;;;;;;;;;;;, Nov. 2020, 53, Suppl.2, 194
後期高齢者に対する肝切除術における栄養障害リスクおよび骨格筋量評価の有用性, ;;;;;;;;;;;;, Nov. 2020, 53, Suppl.2, 195
IPMNと鑑別困難な嚢胞形成を呈した肺癌膵転移の切除例, ;;;;;;;;;;, Nov. 2020, 53, Suppl.2, 260
膵癌における腫瘍間質のTenascin-C高分子バリアントおよび腫瘍細胞表面のAnnexin-A2共発現の予後マーカーとしての有用性, ;;;;;;;;;;, Nov. 2020, 53, Suppl.2, 255
微小肝腫瘍を標的とした術中ソナゾイド造影併用Real-time Virtual Sonographyの有用性, ;;;;;;;;, Oct. 2017, 50, Suppl.2, 273
左腎合併切除を施行した膵体尾部脾臓合併切除の4例, ;;;;;;;;, Oct. 2017, 50, Suppl.2, 426
腫瘤形成型肝内胆管癌における炎症と予後に関する検討, ;;;;;;;;;, Oct. 2017, 50, Suppl.2, 515
肝予備能不良な門脈腫瘍栓合併肝細胞癌に対して左葉切除で切除しえた2例 EOB-MRIによる機能的残肝容積測定の有用性, ;;;;;;;;;, Oct. 2017, 50, Suppl.2, 518
膵頭十二指腸切除術後、トライツ靱帯剥離部より内ヘルニアを発症した1例, ;;;;;;;;, Oct. 2017, 50, Suppl.2, 550
膵頭十二指腸切除術後Braun吻合の腸間膜間隙に発生した内ヘルニアの1例, ;;;;;;;, Jul. 2021, 365回, 47
肝胆膵手術における周術期栄養管理とリハビリテーションの役割 膵頭十二指腸切除術における術前リハビリテーション栄養療法の意義, ;;;;;;;;, Apr. 2021, 121回, SY
膵神経内分泌腫瘍における拡散強調画像の意義, ;;;;;;;;;;;;, Apr. 2021, 121回, SF
肝切除術前の門脈塞栓術症例における機能的残肝評価の有用性と手術適応について, ;;;;;;;;;;;, Apr. 2021, 121回, SF
サルコペニアにおける肝切除後肝再生抑制に関する基礎的研究, ;;;;;;;;;;, Apr. 2021, 121回, SF
3D解析を用いた肝前区域門脈の分岐形態に関する検討, ;;;;;;;;;;, Apr. 2021, 121回, SF
十二指腸乳頭部癌の術前診断・ステージングにおけるFDG-PETの有用性, ;;;;;;;;;, Apr. 2021, 121回, PS
肝切除術におけるNCD risk calculatorを用いた合併症予測の妥当性について, ;;;;;;;;;;, Apr. 2021, 121回, PS
肝切除術中術後の硬膜外麻酔およびIV-PCAによるオピオイド鎮痛と術後胆汁瘻との関連, ;;;;;;;;;;;;, Apr. 2021, 121回, PS
当施設におけるCadaver Surgical Trainingの取り組み, ;;;;;;;;;, Jul. 2021, 76回, P057
肝切除における肝予備能評価のUpdate 拡大肝切除における術前PTPE後の肝静脈塞栓術の意義 Prospective feasibility studyの結果を含めて, ;;;;;;;;;, Jul. 2021, 76回, RS12
深在性膵損傷(III型)に対する診断と治療 外傷性膵損傷(III型)における治療戦略 外傷性膵損傷III型7例の治療経験, ;;;;;;;;, Jul. 2021, 76回, RS14
高齢者に対する膵癌手術の適応と限界 長期成績から考える高齢者膵癌手術における課題, ;;;;;;;;, Jul. 2021, 76回, RS16
胃切除の既往歴が肝切除術術後合併症に与える影響の検討, ;;;;;;;, Jul. 2021, 76回, P162
地域基幹病院における高難度鏡視下手術の安全な実践と後進への教育について カタバートレーニングを活用した腹腔鏡下膵体尾部切除術の定型化, ;;;;;;;;;;, Dec. 2021, 26, 7, CSY11
ICG蛍光法を用いた腹腔鏡下肝亜区域切除における区域間静脈ナビゲーションの可能性, ;;;;;;;;;, Dec. 2021, 26, 7, MO053
血友病合併の肝細胞癌に対し腹腔鏡下肝部分切除術を施行した2例, ;;;;;;;;;, Dec. 2021, 26, 7, MO077
レンバチニブ投与後の稀な合併症2例, ;;;;;;;;;, Mar. 2022, 84, 3, 396
抗原特異的CD8+T細胞誘導マウス腫瘍モデルを用いた動態解析, ;;;;;;;;;;, Oct. 2021, 59回, O15
抗原特異的CD8陽性T細胞の疲弊化誘導における各免疫チェックポイント分子の役割, ;;;;;;;;;;;, Oct. 2021, 59回, O15
【肝胆膵癌におけるconversion therapy】Conversion therapyとは 言葉の定義 induction、rescue、salvage、adjuvantとの違い, ;;;;;;;, May 2022, 84, 5, 561
膵切除周術期栄養療法の意義 膵切除における術前栄養療法、リハビリテーションの有用性, ;;;;;;;;, Apr. 2022, 122回, PD
肝切除後胆汁漏をドレーン中の直接ビリルビン濃度で予測する, ;;;;;;;;;, Apr. 2022, 122回, SF
膵癌におけるTenascin-C高分子バリアントの他臓器浸潤および予後に与える影響の検討, ;;;;;;;;;;, Apr. 2022, 122回, SF
腹部大動脈石灰化体積(AACV)は胆道癌手術における術後合併症の予測因子となる, ;;;;;;;;;, Apr. 2022, 122回, SF
抗PD-1抗体耐性メカニズムにおける疲弊化CD8T細胞での各免疫チェックポイント分子の役割, ;;;;;;;;;;, Apr. 2022, 122回, SF
大腸癌肝転移化学療法後の類洞障害マーカーとしてのAutotaxinの可能性, ;;;;;;;;;, Apr. 2022, 122回, SF
抗原特異的CD8T細胞の疲弊化誘導における各免疫チェックポイント分子の役割, ;;;;;;;;;;, Apr. 2022, 122回, SF
右肝動脈仮性動脈瘤の胆嚢穿破を合併したMirizzi症候群の1例, ;;;;;;;;, Oct. 2021, 82, 増刊, S797
亜全胃温存膵頭十二指腸切除術および胃全摘を同時施行したIPMCと胃噴門部癌併存の一例, ;;;;;;;;;;;, Oct. 2021, 82, 増刊, S1128
カダバーサージカルトレーニングを利用した腹腔鏡下膵体尾部切除術の定型化, ;;;;;;;;;, Jul. 2022, 77回, P032
肝細胞癌に対する肝切除術において抗血栓薬服用が短期成績に与える影響, ;;;;;;;;;, Jul. 2022, 77回, RS8
膵頭十二指腸切除術におけるオステオペニアの意義, ;;;;;;;;;, Jul. 2022, 77回, P063
腹部大動脈石灰化体積(AACV)は胆道癌手術における術後SSIの予測因子となる, ;;;;;;;;;, Jul. 2022, 77回, O26
肝切除術が施行されたエリスロポエチン産生肝細胞癌3例, ;;;;;;;;;, Jul. 2022, 77回, P266
外傷性膵損傷および縦隔内膵仮性嚢胞に対し外科的治療が奏功した1例, ;;;;;;;;;;;, May 2022, 369回, 41
ペムブロリズマブ投与にて、長期生存が得られた肝内胆管癌術後再発の1例, ;;;;;;;;;, May 2022, 369回, 47
先天性胆道拡張症除後の肝内結石症、胆管炎に対する当科での治療経験, ;;;;;;;;;, Sep. 2022, 45, 54
膵臓癌に対するHIKESHI抑制は温熱治療と抗がん剤の治療効果を増強する(Hyperthermia/chemotherapy sensitizing strategy by targeting HIKESHI in refractory pancreatic cancer), ;;;;;;;;;, Sep. 2022, 81回, P
高齢化社会における膵がんに対する治療戦略-短期・長期成績を含めて- 長期予後を目指した高齢者膵癌の治療戦略 骨格筋量と栄養指標から検討した課題と展望, ;;;;;;;;;, Oct. 2022, 60回, OWS6
進行再発大腸がんに対する効果的な外科治療介入を考える 大腸がん肝転移切除症例に対する早期再発とoverall survivalに基づいた切除戦略, ;;;;;;;;;;;;;, Oct. 2022, 60回, OWS28
肝胆膵がんに対する高難度腹腔鏡・ロボット支援手術の定型化と工夫 Cadaver Surgical Trainingによる高難度腹腔鏡下肝切除の安全な導入と定型化について, ;;;;;;;;;;;, Oct. 2022, 60回, OWS29
神経内分泌腫瘍の基礎と臨床 切除可能高分化型膵神経内分泌腫瘍におけるリンパ節転移をDWI-MRIで予測する, ;;;;;;;;;, Oct. 2022, 60回, WS2
がんの微小環境を考える 肝胆膵癌における癌関連線維芽細胞を標的とした新たな治療戦略, ;;;;;;;;;;;, Oct. 2022, 60回, WS4
がん治療におけるサルコペニアとフレイルの意義 がん外科治療、化学療法、免疫療法におけるサルコペニア評価の有用性, ;;;;;;;;;, Oct. 2022, 60回, WS19
抗PD-1抗体に対する耐性メカニズムとしてのTIGITの重要性, ;;;;;;;;;;, Oct. 2022, 60回, YOA O47
肝細胞癌におけるHOIP発現の意義, ;;;;;;;;;;, Oct. 2022, 60回, P19
ペムブロリズマブによる肝内胆管癌の予後改善の可能性, ;;;;;;;;;, Oct. 2022, 60回, P38
まれな膵管内尿細管乳頭状腫瘍(ITPN) 2症例の報告, ;;;;;;;;;, Oct. 2022, 60回, P81
蛍光ガイド肝切除:手技の工夫と成績 腹腔鏡下解剖学的肝切除の区域間認識困難部位におけるICG蛍光法ガイドのコツと有用性について, ;;;;;;;;;, Dec. 2022, 27, 7, 1525
腹腔鏡肝亜区域切除の至適アプローチ:肝門アプローチvs肝内アプローチ 安全性を重視した部位別至適Glissonian approachによる腹腔鏡下肝亜区域切除の手技と成績, ;;;;;;;, Dec. 2022, 27, 7, 2196
【肝胆膵診療のDX(デジタルトランスフォーメーション)新時代】肝胆膵診療のデジタル化の現状 胆膵外科でのDX化はどこまで進んだか, ;;;;;;;;, Feb. 2023, 86, 2, 223
【進化する肝臓外科-高難度腹腔鏡下手術からロボット支援下手術の導入まで】高難度低侵襲肝切除の教育と普及における課題 腹腔鏡下肝切除におけるカダバートレーニングを利用した新規術式導入と教育の意義, ;;;;;;, Mar. 2023, 78, 3, 319
肝細胞癌に対する腹腔鏡下肝切除における新たなアプローチ 肝細胞癌に対する解剖学的特性に基づいた腹腔鏡下肝切除の手技と成績, ;;;;;;;;;, Apr. 2023, 123回, PD
胆道癌肝切除における安全性向上のための周術期管理 機能的残肝容積と支持療法を主軸とした胆道癌肝切除の周術期治療戦略, ;;;;;;;;;, Apr. 2023, 123回, WS
低栄養の評価は何を用いるか?GLIM基準を中心として 肝細胞癌切除患者におけるGLIM基準の意義, ;;;;;;;;, Apr. 2023, 123回, WS
抗原特異的CD8陽性T細胞の賦活化を介した抗PD-1抗体と抗TIGIT抗体併用腫瘍免疫療法の分子機序解明, ;;;;;;;;;;, Apr. 2023, 123回, SF
肝胆膵高難度手術におけるfailure to rescue低下にむけた合併症対策, ;;;;;;;;;, Apr. 2023, 123回, DP
肝臓癌重粒子線治療後の照射野内局所再発に対してサルベージ肝切除術を施行した5例の臨床的検討, ;;;;;;;;;;;, Apr. 2023, 123回, DP
大腸癌肝転移切除における再発時臨床因子と切除後予後(Overall Survival)に関する検討, ;;;;;;;;;, Apr. 2023, 123回, DP
Fibrolamellar hepatocellular carcinomaの切除例に関するRNA seq解析を含めた検討, ;;;;;;;;;;;;;;, Oct. 2022, 55, Suppl.2, 155
肝切除術前の門脈塞栓術における肝再生肥大とサルコペニアの関連性について, ;;;;;;;;;, Oct. 2022, 55, Suppl.2, 174
肝細胞癌に対する肝切除における亜鉛欠乏症の意義, ;;;;;;;;;, Oct. 2022, 55, Suppl.2, 321
肝切除術における蛍光内視鏡外科の有用性 腹腔鏡下解剖学的肝切除におけるICG蛍光ナビゲーションの有用性, ;;;;;;;;;, May 2023, 48, 3, 297
【超高齢社会における肝胆膵疾患診療】高齢者における膵癌の外科治療, ;;;;;;;;;, Jun. 2023, 86, 6, 771
代償性肝肥大効果の増強を目的とした門脈塞栓術後の逐次的・頸静脈的肝静脈塞栓術の初期経験, ;;;;;;;;;, Apr. 2023, 38, Suppl., 201
【総論】術後合併症発生後のFailure to Rescue回避の取り組み 高難度肝胆膵外科手術におけるFTR回避のための取り組み, ;;;;;;;;;, Jul. 2023, 78回, WS6
S7/S8領域と尾状葉を扱う高難度腹腔鏡下肝切除の定型化に向けた手技と成績, ;;;;;;;;;, Jul. 2023, 78回, O12
術後早期ドレーン感染に注目した膵頭十二指腸切除後膵液瘻に対する周術期管理戦略, ;;;;;;;;;, Jul. 2023, 78回, O25
CRAFITYscoreからみた肝細胞癌術後遠隔・肝内多発再発に対する治療戦略, ;;;;;;;;;, Jul. 2023, 78回, O43
ドレーン中直接ビリルビン濃度とドレーン排液量による肝切除後胆汁漏の予測の検討, ;;;;;;;;;, Jul. 2023, 78回, RS18
20mm以下の非機能性膵神経内分泌腫瘍におけるリンパ節郭清の意義と郭清範囲の検討, ;;;;;;;;;, Jul. 2023, 78回, RS19
肝胆膵外科手術成績向上にむけた術前フレイルチェックの実践, ;;;;;;;;;, Jul. 2023, 78回, P144
【気になるポイント"即"チェック!キーワード45でサクッと理解 消化器ドレーン・チューブ事典】留置位置別ドレーン・チューブ, 塚越 真梨子, Sep. 2023, 28, 9, 845
胆道癌に対する肝切除+肝外胆管切除術の術後合併症予測における機能的残肝容積(functional FRLV)の有用性, ;;;;;;;;;, Aug. 2023, 37, 3, 554
肝癌治療における栄養評価と介入の意義 肝癌外科治療における栄養評価と介入の意義, ;;, Sep. 2023, 64, Suppl.2, A581
腹腔鏡下肝亜区域切除の手術成績に基づく安全性と有用性の検討, ;;;;;;;;, Dec. 2023, 28, 7, 164
蛍光ナビゲーション低侵襲肝切除術の進歩 蛍光ナビゲーションによる腹腔鏡下肝亜区域切除の意義 開腹亜区域切除と比較した有用性について, ;;;;;;;;, Dec. 2023, 28, 7, 826
安全な腹腔鏡下膵体尾部切除術の確立とロボット支援下膵体尾部切除術の導入, ;;;;;;;;, Dec. 2023, 28, 7, 892
再発時CRAFITY scoreからみた高悪性度肝細胞癌の同定とその治療戦略, ;;;;;;;;;, Nov. 2023, 56, Suppl.2, 342
【体腔鏡手術の教え方・学び方】肝胆膵 腹腔鏡下肝切除におけるカダバートレーニングの教育的意義, ;;;;;;;, Mar. 2024, 86, 3, 255
大腸癌肝転移切除における外科的切除不能(Surgical Failure)再発と予後に関する検討, ;;;;;;;;;;, Oct. 2023, 61回, O49
肝細胞癌切除症例の再発形式から見た術前・術後治療を必要とする高悪性度症例の同定, ;;;;;;;;, Oct. 2023, 61回, O49
群大肝胆膵外科のあれから, ;;;;;;;;;;;;;;, Apr. 2024, 124回, SP
胆道癌肝切除における死亡率ゼロへの挑戦 胆道癌肝切除死亡率ゼロを目指した手術適応戦略 機能的残肝容積(fFRLV)と門脈・肝静脈塞栓を駆使した適応決定について, ;;;;;;;;;;;, Apr. 2024, 124回, SY
高齢者に対する周術期管理の新たなエビデンスの構築に向けて 高齢者肝胆膵外科術後のADL低下予測 オーラルフレイル評価と握力測定の有用性, ;;;;;;;;;;, Apr. 2024, 124回, WS
肝細胞癌切除症例の再発形式から見た切除可能境界領域肝細胞癌とは, ;;;;;;;;;;;;, Apr. 2024, 124回, SF
閉塞性黄疸におけるM2BPGiの上昇とその変動に関する検討, ;;;;;;;;;, Apr. 2024, 124回, SF
RNF31は,NF-κB活性化を介し,肝細胞癌の増殖・浸潤を促進する, ;;;;;;;;;;, Apr. 2024, 124回, PS
外傷性膵・胆道系損傷に対する病態毎の治療法選択と短期・長期成績について, ;;;;;;;;;;, Apr. 2024, 124回, PS
高齢者肝細胞癌患者の術後ADLを損なわない腹腔鏡下肝切除 開腹肝切除との比較, ;;;;;;;;;;, Apr. 2024, 124回, PS
切除可能胆管癌における18F-FDG-PETの予後予測マーカーとしての有用性, ;;;;;;;;;;;, Apr. 2024, 124回, PS
胆道癌切除患者におけるGLIM基準による低栄養の意義, ;;;;;;;;;;, Apr. 2024, 124回, PS
急性肝不全治療における新たな肝再生因子の可能性, ;;;;;;;;;;;;, May 2024, 65, 5, 253
遺伝性楕円赤血球症に合併した肝内結石症の1例, ;;;;;;;;;;;, Feb. 2024, 378回, 34
ACTH産生膵神経内分泌腫瘍の2例, ;;;;;;;;;;;, Feb. 2024, 378回, 38
肝切除におけるナビゲーションの展開 腹腔鏡下肝亜区域切除術におけるICG蛍光ナビゲーションの有用性, ;;;;;;;;;;;, May 2024, 49, 3, 270
外科治療におけるGLIM criteriaの意義を考える 肝細胞癌切除患者における握力を用いたGLIM基準の有用性, ;;;;;;;, Oct. 2023, 84, 増刊, S189
ACTH産生膵神経内分泌腫瘍の2例, ;;;;;;;;;;, Oct. 2023, 84, 増刊, S367
肝胆膵 高難度腹腔鏡下肝切除の定型化に向けて 主肝静脈根部を扱う高難度腹腔鏡下肝切除の定型化と若手術者教育の取り組み, ;;;;;;;;;, Jul. 2024, 79回, 447
肝胆膵 腹腔鏡下・ロボット支援下肝切除時代の肝機能から見た術式選択を再考する 肝癌における肝機能不良,高度線維化に着目した低侵襲性肝切除の意義について, ;;;;;;;;;, Jul. 2024, 79回, 636
高齢者膵癌患者の周術期治療の成績と対策, ;;;;;;;;, Jul. 2024, 79回, 694
新たな定義によるBR肝細胞癌の予後解析, ;;;;;;;;;, Jul. 2024, 79回, 1261
75歳以上の高齢者膵癌患者に対する膵頭十二指腸切除術の治療成績, ;;;;;;;;;, Jul. 2024, 79回, 1655
胆道癌におけるクレアチニン/シスタチンC比のサルコペニア及び術後予後予測マーカーとして有用性, ;;;;;;;;;, Jul. 2024, 79回, 2049
右肝静脈のシャント形成により肝左三区域切除術で切除し得た肝門部領域IPNBの一例, ;;;;;;;;;;;;, Apr. 2024, 379回, 34
フコシル化α1-酸性糖蛋白質は肝胆膵悪性腫瘍に有用な診断マーカーである(Fucosylated α1-acid glycoprotein is a promising diagnostic marker for hepatobiliary and pancreatic malignant tumors), ;;;;;;;;;;;;;;;;, Sep. 2024, 83回, P
新規肝再生促進因子であるGRP78はマウス肝癌細胞の腫瘍悪性度を亢進する(GRP78, a new hepatotrophic factor, increases the aggressiveness of mouse hepatocellular carcinoma cells), ;;;;;;;;;;;;;;;;, Sep. 2024, 83回, P
解剖学的Resectable膵癌切除例における、生物学的Borderline resectable膵癌の検討, ;;;;;;;;;;;, Oct. 2024, 62回, O46
【進化する肝胆膵ロボティックス】肝臓 ロボット支援下肝切除の導入とラーニングカーブ, ;;;;, Jan. 2025, 90, 1, 33
Unclassified hepatocellular adenoma with beta-catenin mutation: a case report., Muranushi Ryo;Araki Kenichiro;Harimoto Norifumi;Yokobori Takehiko;Hoshino Kouki;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Aishima Shinichi;Shirabe Ken, Feb. 2021, Surgical case reports, 7, 1
Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68., Yamanaka Takahiro;Harimoto Norifumi;Yokobori Takehiko;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Gantumur Dolgormaa;Handa Tadashi;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Umezawa Kazuo;Shirabe Ken, Mar. 2021, Molecular cancer therapeutics, 20, 6
Hepatic stellate cell as a Mac-2-binding protein-producing cell in patients with liver fibrosis., Gantumur Dolgormaa;Harimoto Norifumi;Muranushi Ryo;Hoshino Kouki;Batbayar Chingun;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Araki Kenichiro;Yokobori Takehiko;Aishima Shinichi;Shirabe Ken, Apr. 2021, Hepatology research : the official journal of the Japan Society of Hepatology, 51, 10
FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis., Watanabe Akira;Harimoto Norifumi;Araki Kenichiro;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Hirai Keitaro;Tanaka Hiroshi;Mochida Yasushi;Kogure Norimichi;Higuchi Tetsuya;Shirabe Ken, May 2021, Journal of surgical oncology, 124, 3
High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence., Muranushi Ryo;Araki Kenichiro;Yokobori Takehiko;Chingunjav Batbayar;Hoshino Kouki;Dolgormaa Gantumur;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Harimoto Norifumi;Shimoda Yuki;Sano Rie;Oyama Tetsunari;Saeki Hiroshi;Shirabe Ken, Jun. 2021, Cancer science, 112, 8
Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy., Tsukagoshi Mariko;Harimoto Norifumi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Ishii Norihiro;Yamanaka Takahiro;Hagiwara Kei;Hoshino Kouki;Muranushi Ryo;Yajima Toshiki;Wada Naoki;Shirabe Ken, Jun. 2021, International journal of clinical oncology, 26, 9
Prediction with functional liver volume assessment to achieve the resection limit after portal vein embolization in patients scheduled major hepatectomy., Araki Kenichiro;Harimoto Norifumi;Shibuya Kei;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Tsushima Yoshito;Shirabe Ken, Jun. 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association, 24, 2
Gastrectomy history as a predictor of post-hepatectomy complications., Harimoto Norifumi;Araki Kenichiro;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shirabe Ken, Aug. 2021, Surgery today, 52, 3
Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy., Tsukagoshi Mariko;Harimoto Norifumi;Araki Kenichiro;Kubo Norio;Watanabe Akira;Igarashi Takamichi;Ishii Norihiro;Yamanaka Takahiro;Hagiwara Kei;Hoshino Kouki;Muranushi Ryo;Yajima Toshiki;Shirabe Ken, Aug. 2021, Cancers, 13, 16
Direct Bilirubin in Drainage Fluid 3 days after Hepatectomy Is Useful for Detecting Severe Bile Leakage., Harimoto Norifumi;Araki Kenichiro;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Shirabe Ken, Aug. 2021, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 63, 1
Does intraoperative and postoperative analgesia cause bile leakage after hepatectomy?, Igarashi Takamichi;Harimoto Norifumi;Muranushi Ryo;Yamanaka Takahiro;Hagiwara Kei;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Kubo Norio;Araki Kenichiro;Saito Shigeru;Shirabe Ken, Sep. 2021, Surgery today, 52, 4
Significance of zinc deficiency in patients with hepatocellular carcinoma undergoing hepatic resection., Harimoto Norifumi;Araki Kenichiro;Muranushi Ryo;Hoshino Kouki;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Shirabe Ken, Nov. 2021, Hepatology research : the official journal of the Japan Society of Hepatology, 52, 2
Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response., Harimoto Norifumi;Itoh Shinji;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Araki Kenichiro;Yoshizumi Tomoharu;Shirabe Ken, Anticancer research, 42, 1
The ratio of creatinine and cystatin C estimated glomerular filtration rates as a surrogate marker in patients with hepatocellular carcinoma undergoing hepatic resection., Harimoto Norifumi;Araki Kenichiro;Yamanaka Takahiro;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Takizawa Makiko;Yokobori Takehiko;Shirabe Ken, May 2022, Journal of hepato-biliary-pancreatic sciences, 29, 9
A new liver regeneration molecular mechanism involving hepatic stellate cells, Kupffer cells, and glucose-regulated protein 78 as a new hepatotrophic factor., Hagiwara Kei;Harimoto Norifumi;Yamanaka Takahiro;Ishii Norihiro;Yokobori Takehiko;Tsukagoshi Mariko;Watanabe Akira;Araki Kenichiro;Yoshizumi Tomoharu;Shirabe Ken, May 2022, Journal of hepato-biliary-pancreatic sciences, 30, 2
A case of Mirizzi syndrome accompanied by a pseudoaneurysm that ruptured into the gallbladder: successfully treated by embolization of aneurysm and sequential surgery., Fukushima Ryosuke;Ishii Norihiro;Harimoto Norifumi;Araki Kenichiro;Watanabe Akira;Tsukagoshi Mariko;Hagiwara Kei;Yamanaka Takahiro;Shirabe Ken, Jun. 2022, Surgical case reports, 8, 1
A prospective study of sequential hepatic vein embolization after portal vein embolization in patients scheduled for right-sided major hepatectomy: Results of feasibility and surgical strategy using functional liver assessment., Araki Kenichiro;Shibuya Kei;Harimoto Norifumi;Watanabe Akira;Tsukagoshi Mariko;Ishii Norihiro;Ikota Hayato;Yokobori Takehiko;Tsushima Yoshito;Shirabe Ken, Jul. 2022, Journal of hepato-biliary-pancreatic sciences, 30, 1
Study on the portal ramification pattern of the right anterior sector of the liver and a unique medial branch (PV8c) of the right anterior portal vein., Ishii Norihiro;Harimoto Norifumi;Kogure Kimitaka;Araki Kenichiro;Hagiwara Kei;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Shirabe Ken, Mar. 2022, Annals of gastroenterological surgery, 6, 5
Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report., Seki Takaomi;Tsukagoshi Mariko;Harimoto Norifumi;Araki Kenichiro;Watanabe Akira;Ishii Norihiro;Hagiwara Kei;Hoshino Kouki;Muranushi Ryo;Kakizaki Satoru;Ogawa Yoshiyuki;Handa Hiroshi;Shirabe Ken, Oct. 2022, Surgical case reports, 8, 1
Abdominal aortic calcification volume (AACV) is a predictive factor for postoperative complications associated with biliary tract cancer., Watanabe Akira;Harimoto Norifumi;Araki Kenichiro;Tsukagoshi Mariko;Ishii Norihiro;Hagiwara Kei;Yamanaka Takahiro;Hoshino Kouki;Muranushi Ryo;Shirabe Ken, Nov. 2022, Surgery today, 53, 2
Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy., Yamanaka Takahiro;Harimoto Norifumi;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Araki Kenichiro;Shirabe Ken, Anticancer research, 42, 12
Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators., Araki Kenichiro;Harimoto Norifumi;Shibuya Kei;Watanabe Akira;Tsukagoshi Mariko;Ishii Norihiro;Hagiwara Kei;Muranushi Ryo;Hoshino Kouki;Seki Takaomi;Shirabe Ken, Anticancer research, 43, 1
Autotaxin is a novel surrogate marker for oxaliplatin-related sinusoidal obstruction syndrome in patients with colorectal liver metastasis., Ishii Norihiro;Harimoto Norifumi;Seki Takaomi;Muranushi Ryo;Hagiwara Kei;Tsukagoshi Mariko;Watanabe Akira;Yoshida Yuka;Araki Kenichiro;Shirabe Ken, Apr. 2023, Hepatology research : the official journal of the Japan Society of Hepatology, 53, 8
Laparoscopic Liver Resection Procedure Attenuates Organ-space Surgical Site Infection Compared With Open Procedure: A Propensity Score-matched Analysis., Araki Kenichiro;Harimoto Norifumi;Watanabe Akira;Tsukagoshi Mariko;Ishii Norihiro;Hagiwara Kei;Muranushi Ryo;Hoshino Kouki;Seki Takaomi;Shirabe Ken, Anticancer research, 43, 5
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer., Batbayar Chingunjav;Ishii Norihiro;Harimoto Norifumi;Yokobori Takehiko;Saito Hideyuki;Gantumur Dolgormaa;Gombodorj Navchaa;Erkhem-Ochir Bilguun;Muranushi Ryo;Hoshino Kouki;Yamanaka Takahiro;Hagiwara Kei;Tsukagoshi Mariko;Watanabe Akira;Araki Kenichiro;Hosouchi Yasuo;Shirabe Ken, Apr. 2023, International journal of clinical oncology, 28, 7
Significance of malnutrition defined with Global Leadership Initiative on Malnutrition criteria in patients with hepatocellular carcinoma after hepatic resection., Harimoto Norifumi;Tsukagoshi Mariko;Okuyama Takayuki;Hoshino Kouki;Hagiwara Kei;Kawai Shunsuke;Ishii Norihiro;Igarashi Takamichi;Araki Kenichiro;Shirabe Ken, Sep. 2023, Hepatology research : the official journal of the Japan Society of Hepatology, 53, 12
Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer., Tsukagoshi Mariko;Watanabe Akira;Araki Kenichiro;Ishii Norihiro;Hagiwara Kei;Hoshino Kouki;Muranushi Ryo;Harimoto Norifumi;Takizawa Makiko;Shirabe Ken, Apr. 2023, Annals of gastroenterological surgery, 7, 5
Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases., Tsukagoshi Mariko;Harimoto Norifumi;Araki Kenichiro;Ishii Norihiro;Hagiwara Kei;Hoshino Kouki;Yanagisawa Kunio;Ogawa Yoshiyuki;Handa Hiroshi;Shirabe Ken, Sep. 2023, Clinical journal of gastroenterology, 16, 6
A case of cholangiocarcinoma complicating liver abscess-related tumor thrombus extending via the inferior vena cava to the right ventricle and visualized on transthoracic echocardiography., Kato Toshimitsu;Yanagisawa Kunio;Okada Kenya;Tsukagoshi Mariko;Tokue Yutaka;Shirabe Ken;Tsushima Yoshito, Sep. 2023, Journal of medical ultrasonics (2001), 51, 1
Fibrolamellar hepatocellular carcinoma: a case report and gene analysis., Watanabe Akira;Harimoto Norifumi;Saito Hideyuki;Kawabata-Iwakawa Reika;Seki Takaomi;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Araki Kenichiro;Ikota Hayato;Ishige Takashi;Mimori Koshi;Shirabe Ken, Sep. 2023, Surgical case reports, 9, 1
Liver regeneration after hepatectomy is significantly suppressed in a muscular atrophy mouse model., Hagiwara Kei;Watanabe Akira;Harimoto Norifumi;Araki Kenichiro;Yokobori Takehiko;Muranushi Ryo;Hoshino Kouki;Ishii Norihiro;Tsukagoshi Mariko;Shirabe Ken, Nov. 2023, Journal of hepato-biliary-pancreatic sciences, 31, 3
The impact of lymphangiograpy on chyle leakage treatment duration after pancreatic surgery., Ishii Norihiro;Harimoto Norifumi;Seki Takamomi;Muranushi Ryo;Hagiwara Kei;Hoshino Kouki;Tsukagoshi Mariko;Watanabe Akira;Igarashi Takamichi;Shibuya Kei;Araki Kenichiro;Shirabe Ken, Dec. 2023, Surgery today, 54, 6
RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation., Hoshino Kouki;Nakazawa Seshiru;Yokobori Takehiko;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Araki Kenichiro;Harimoto Norifumi;Tokunaga Fuminori;Shirabe Ken, Jan. 2024, Scientific reports, 14, 1
Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC., Harimoto Norifumi;Tsukagoshi Mariko;Seki Takaomi;Hoshino Kouki;Hagiwara Kei;Ishii Norihiro;Igarashi Takamichi;Araki Kenichiro;Haruki Koichiro;Ikegami Toru;Shirabe Ken, Jan. 2024, International journal of clinical oncology, 29, 2
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer., Yamanaka Takahiro;Araki Kenichiro;Yokobori Takehiko;Muranushi Ryo;Hoshino Kouki;Hagiwara Kei;Gantumur Dolgormaa;Ishii Norihiro;Tsukagoshi Mariko;Watanabe Akira;Harimoto Norifumi;Masamune Atsushi;Uojima Haruki;Mizokami Masashi;Ito Kiyoaki;Shirabe Ken, Feb. 2024, Cancer science
Total lesion glycolysis by 18 F-fluorodeoxyglucose positron emission tomography predicts tumor aggressiveness in patients with extrahepatic bile duct carcinoma., Fukushima Ryosuke;Harimoto Norifumi;Kawai Shunsuke;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Araki Kenichiro;Tomonaga Hiroyasu;Higuchi Tetsuya;Shirabe Ken, Mar. 2024, Journal of hepato-biliary-pancreatic sciences
Perioperative pancreaticoduodenectomy management strategy focusing on postoperative early drain colonization., Watanabe Akira;Harimoto Norifumi;Araki Kenichiro;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Hagiwara Kei;Tsunekawa Katsuhiko;Murakami Masami;Shirabe Ken, Mar. 2024, Surgery today, 54, 9
Therapeutic management for liver metastases of gastrointestinal stromal tumor(GIST), ;;;;;;, Nov. 2016, 71, 12, 1366, 1371
A novel and safe technique for esophagojejunostomy using the direct inserted anvil after laparoscopy assisted total gastrectomy, ;;;;;, May 2014, 19, 3, 323, 327
膵切除周術期栄養療法の意義 膵切除における術前栄養療法、リハビリテーションの有用性, ;;;;;;;;, Apr. 2022, 122回, PD
肝切除後胆汁漏をドレーン中の直接ビリルビン濃度で予測する, ;;;;;;;;;, Apr. 2022, 122回, SF
膵癌におけるTenascin-C高分子バリアントの他臓器浸潤および予後に与える影響の検討, ;;;;;;;;;;, Apr. 2022, 122回, SF
腹部大動脈石灰化体積(AACV)は胆道癌手術における術後合併症の予測因子となる, ;;;;;;;;;, Apr. 2022, 122回, SF
抗PD-1抗体耐性メカニズムにおける疲弊化CD8T細胞での各免疫チェックポイント分子の役割, ;;;;;;;;;;, Apr. 2022, 122回, SF
大腸癌肝転移化学療法後の類洞障害マーカーとしてのAutotaxinの可能性, ;;;;;;;;;, Apr. 2022, 122回, SF
抗原特異的CD8T細胞の疲弊化誘導における各免疫チェックポイント分子の役割, ;;;;;;;;;;, Apr. 2022, 122回, SF
【肝胆膵癌におけるconversion therapy】Conversion therapyとは 言葉の定義 induction、rescue、salvage、adjuvantとの違い, ;;;;;;;, May 2022, 84, 5, 561
右肝動脈仮性動脈瘤の胆嚢穿破を合併したMirizzi症候群の1例, ;;;;;;;;, Oct. 2021, 82, 増刊, S797
亜全胃温存膵頭十二指腸切除術および胃全摘を同時施行したIPMCと胃噴門部癌併存の一例, ;;;;;;;;;;;, Oct. 2021, 82, 増刊, S1128
カダバーサージカルトレーニングを利用した腹腔鏡下膵体尾部切除術の定型化, ;;;;;;;;;, Jul. 2022, 77回, P032
肝細胞癌に対する肝切除術において抗血栓薬服用が短期成績に与える影響, ;;;;;;;;;, Jul. 2022, 77回, RS8
膵頭十二指腸切除術におけるオステオペニアの意義, ;;;;;;;;;, Jul. 2022, 77回, P063
腹部大動脈石灰化体積(AACV)は胆道癌手術における術後SSIの予測因子となる, ;;;;;;;;;, Jul. 2022, 77回, O26
肝切除術が施行されたエリスロポエチン産生肝細胞癌3例, ;;;;;;;;;, Jul. 2022, 77回, P266
外傷性膵損傷および縦隔内膵仮性嚢胞に対し外科的治療が奏功した1例, ;;;;;;;;;;;, May 2022, 369回, 41
ペムブロリズマブ投与にて、長期生存が得られた肝内胆管癌術後再発の1例, ;;;;;;;;;, May 2022, 369回, 47
肝切除術における蛍光内視鏡外科の有用性 腹腔鏡下解剖学的肝切除におけるICG蛍光ナビゲーションの有用性, ;;;;;;;;;, May 2023, 48, 3, 297
代償性肝肥大効果の増強を目的とした門脈塞栓術後の逐次的・頸静脈的肝静脈塞栓術の初期経験, ;;;;;;;;;, Apr. 2023, 38, Suppl., 201
【超高齢社会における肝胆膵疾患診療】高齢者における膵癌の外科治療, ;;;;;;;;;, Jun. 2023, 86, 6, 771
【総論】術後合併症発生後のFailure to Rescue回避の取り組み 高難度肝胆膵外科手術におけるFTR回避のための取り組み, ;;;;;;;;;, Jul. 2023, 78回, WS6
S7/S8領域と尾状葉を扱う高難度腹腔鏡下肝切除の定型化に向けた手技と成績, ;;;;;;;;;, Jul. 2023, 78回, O12
術後早期ドレーン感染に注目した膵頭十二指腸切除後膵液瘻に対する周術期管理戦略, ;;;;;;;;;, Jul. 2023, 78回, O25
CRAFITYscoreからみた肝細胞癌術後遠隔・肝内多発再発に対する治療戦略, ;;;;;;;;;, Jul. 2023, 78回, O43
ドレーン中直接ビリルビン濃度とドレーン排液量による肝切除後胆汁漏の予測の検討, ;;;;;;;;;, Jul. 2023, 78回, RS18
20mm以下の非機能性膵神経内分泌膿瘍におけるリンパ節郭清の意義と郭清範囲の検討, ;;;;;;;;;, Jul. 2023, 78回, RS19
肝胆膵外科手術成績向上にむけた術前フレイルチェックの実践, ;;;;;;;;;, Jul. 2023, 78回, P144
【気になるポイント"即"チェック!キーワード45でサクッと理解 消化器ドレーン・チューブ事典】留置位置別ドレーン・チューブ, 塚越 真梨子, Sep. 2023, 28, 9, 845
胆道癌に対する肝切除+肝外胆管切除術の術後合併症予測における機能的残肝容積(functional FRLV)の有用性, ;;;;;;;;;, Aug. 2023, 37, 3, 554
肝癌治療における栄養評価と介入の意義 肝癌外科治療における栄養評価と介入の意義, ;;, Sep. 2023, 64, Suppl.2, A581
大腸癌肝転移切除における外科的切除不能(Surgical Failure)再発と予後に関する検討, ;;;;;;;;;;, Oct. 2023, 61回, O49
肝細胞癌切除症例の再発形式から見た術前・術後治療を必要とする高悪性度症例の同定, ;;;;;;;;, Oct. 2023, 61回, O49
腹腔鏡下肝亜区域切除の手術成績に基づく安全性と有用性の検討, ;;;;;;;;, Dec. 2023, 28, 7, 164
蛍光ナビゲーション低侵襲肝切除術の進歩 蛍光ナビゲーションによる腹腔鏡下肝亜区域切除の意義 開腹亜区域切除と比較した有用性について, ;;;;;;;;, Dec. 2023, 28, 7, 826
安全な腹腔鏡下膵体尾部切除術の確立とロボット支援下膵体尾部切除術の導入, ;;;;;;;;, Dec. 2023, 28, 7, 892
再発時CRAFITY scoreからみた高悪性度肝細胞癌の同定とその治療戦略, ;;;;;;;;;, Nov. 2023, 56, Suppl.2, 342
【体腔鏡手術の教え方・学び方】肝胆膵 腹腔鏡下肝切除におけるカダバートレーニングの教育的意義, ;;;;;;;, Mar. 2024, 86, 3, 255
群大肝胆膵外科のあれから, ;;;;;;;;;;;;;;, Apr. 2024, 124回, SP
胆道癌肝切除における死亡率ゼロへの挑戦 胆道癌肝切除死亡率ゼロを目指した手術適応戦略 機能的残肝容積(fFRLV)と門脈・肝静脈塞栓を駆使した適応決定について, ;;;;;;;;;;;, Apr. 2024, 124回, SY
高齢者に対する周術期管理の新たなエビデンスの構築に向けて 高齢者肝胆膵外科術後のADL低下予測 オーラルフレイル評価と握力測定の有用性, ;;;;;;;;;;, Apr. 2024, 124回, WS
肝細胞癌切除症例の再発形式から見た切除可能境界領域肝細胞癌とは, ;;;;;;;;;;;;, Apr. 2024, 124回, SF
閉塞性黄疸におけるM2BPGiの上昇とその変動に関する検討, ;;;;;;;;;, Apr. 2024, 124回, SF
RNF31は,NF-κB活性化を介し,肝細胞癌の増殖・浸潤を促進する, ;;;;;;;;;;, Apr. 2024, 124回, PS
外傷性膵・胆道系損傷に対する病態毎の治療法選択と短期・長期成績について, ;;;;;;;;;;, Apr. 2024, 124回, PS
高齢者肝細胞癌患者の術後ADLを損なわない腹腔鏡下肝切除 開腹肝切除との比較, ;;;;;;;;;;, Apr. 2024, 124回, PS
切除可能胆管癌における18F-FDG-PETの予後予測マーカーとしての有用性, ;;;;;;;;;;;, Apr. 2024, 124回, PS
胆道癌切除患者におけるGLIM基準による低栄養の意義, ;;;;;;;;;;, Apr. 2024, 124回, PS
急性肝不全治療における新たな肝再生因子の可能性, ;;;;;;;;;;;;, May 2024, 65, 5, 253
肝切除におけるナビゲーションの展開 腹腔鏡下肝亜区域切除術におけるICG蛍光ナビゲーションの有用性, ;;;;;;;;;;;, May 2024, 49, 3, 270
遺伝性楕円赤血球症に合併した肝内結石症の1例, ;;;;;;;;;;;, Feb. 2024, 378回, 34
ACTH産生膵神経内分泌腫瘍の2例, ;;;;;;;;;;;, Feb. 2024, 378回, 38
外科治療におけるGLIM criteriaの意義を考える 肝細胞癌切除患者における握力を用いたGLIM基準の有用性, ;;;;;;;, Oct. 2023, 84, 増刊, S189
ACTH産生膵神経内分泌腫瘍の2例, ;;;;;;;;;;, Oct. 2023, 84, 増刊, S367
肝胆膵 高難度腹腔鏡下肝切除の定型化に向けて 主肝静脈根部を扱う高難度腹腔鏡下肝切除の定型化と若手術者教育の取り組み, ;;;;;;;;;, Jul. 2024, 79回, 447
肝胆膵 腹腔鏡下・ロボット支援下肝切除時代の肝機能から見た術式選択を再考する 肝癌における肝機能不良,高度線維化に着目した低侵襲性肝切除の意義について, ;;;;;;;;;, Jul. 2024, 79回, 636
高齢者膵癌患者の周術期治療の成績と対策, ;;;;;;;;, Jul. 2024, 79回, 694
新たな定義によるBR肝細胞癌の予後解析, ;;;;;;;;;, Jul. 2024, 79回, 1261
75歳以上の高齢者膵癌患者に対する膵頭十二指腸切除術の治療成績, ;;;;;;;;;, Jul. 2024, 79回, 1655
胆道癌におけるクレアチニン/シスタチンC比のサルコペニア及び術後予後予測マーカーとして有用性, ;;;;;;;;;, Jul. 2024, 79回, 2049
右肝静脈のシャント形成により肝左三区域切除術で切除し得た肝門部領域IPNBの一例, ;;;;;;;;;;;;, Apr. 2024, 379回, 34
フコシル化α1-酸性糖蛋白質は肝胆膵悪性腫瘍に有用な診断マーカーである(Fucosylated α1-acid glycoprotein is a promising diagnostic marker for hepatobiliary and pancreatic malignant tumors), ;;;;;;;;;;;;;;;;, Sep. 2024, 83回, P
新規肝再生促進因子であるGRP78はマウス肝癌細胞の腫瘍悪性度を亢進する(GRP78, a new hepatotrophic factor, increases the aggressiveness of mouse hepatocellular carcinoma cells), ;;;;;;;;;;;;;;;;, Sep. 2024, 83回, P
解剖学的Resectable膵癌切除例における、生物学的Borderline resectable膵癌の検討, ;;;;;;;;;;;, Oct. 2024, 62回, O46
【進化する肝胆膵ロボティックス】肝臓 ロボット支援下肝切除の導入とラーニングカーブ, ;;;;, Jan. 2025, 90, 1, 33